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ABSTRACT
Cellular spheroids are attractive for tissue fabrication due to having precise
control over cell and extracellular matrix (ECM) composition, the ability for upscaled
production and repeatability, their three-dimensional nature and the fact that spheroids
will produce their own ECM over time. A critical process in the fabrication of complex
tissue structures with cellular spheroids is related to their fusion and maturation. Tissue
fusion is a self-assembly process in which two or more distinct cell populations, or
tissues, make contact and coalesce to form a single cohesive structure. Maturation of
tissue engineered constructs involves developing the mechanical properties and ECM
compositions that mimic native vasculature. However, the fusion and maturation of
spheroids and tissues composed of spheroids over time is not clearly understood.
Therefore, developing methods to understand and accelerate the fusion and maturation of
tissues composed of spheroids will improve upon current techniques for tissue fabrication
with spheroids. Here, the fusion and maturation of vascular tissues mediated by magnetic
forces was modeled using Janus Magnetic Cellular Spheroids (JMCSs). JMCSs contain
two distinct domains: cells and extracellular iron oxide magnetic nanoparticles (MNPs).
This separation of cells and MNPs has no adverse effects on long-term viability or
cellular phenotype, allowing for magnetic manipulation of spheroids for building larger
tissues.
Here, spheroid composition was manipulated, by varying ECM and cell contents,
in order to study the resulting effects on JMCS fusion mediated by magnetic forces. Next,
the influence of iron oxide MNPs on ECM production in JMCSs was studied over time.
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Further, magnetic sheets composed of JMCSs were fabricated and their maturation
mediated by cyclic longitudinal stretching using magnetic forces. The objective of this
work was to determine the mechanisms associated with the fusion and maturation of
JMCSs and tissues composed of JMCSs. The hypotheses driving this work were that
spheroid composition dictates their fusion and that magnetic forces can be utilized to
dynamically condition tissues composed of JMCSs for maturation.
Results demonstrated the critical importance of magnetic forces for promoting the
fusion of JMCSs, when compared to JMCSs not exposed to magnetic forces. Further,
results demonstrate the critical role of cell-cell and cell-ECM interactions for mediating
cellular spheroid fusion over time. Results showed that the addition of iron oxide
magnetic nanoparticles in JMCSs caused a significant increase in collagen production,
when compared to no iron oxide controls. Quantitative results demonstrate that cyclic
longitudinal stretching of tissue sheets mediated by magnetic forces increases the
Young’s modulus, enhances ECM production and induces collagen fiber alignment over
7 days, when compared to statically conditioned controls. These findings are expected to
provide a strong theoretical and methodological foundation for the development of new
tissue engineering technologies.
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CHAPTER 1
BACKGROUND
1.1 VASCULAR TISSUE ENGINEERING
Cardiovascular diseases can result in numerous forms of life threatening events,
such as coronary obstructions, spasms, rhythm disturbances, infections, acquired
deformities, congenital malformations etc., with atherosclerosis remaining the leading
cause of death in the United States. Although the death rates of cardiovascular diseases
have declined, it remains a severe medical problem in the United States to address [1].
According to a report from the American Heart Association in 2010, more than 1/3 adults
have some form of cardiovascular disease and the total cost for cardiovascular disease
and stroke in the United States was $503.2 Billion [2]. Even more, a report by the
American Heart Association in 2011 noted that each year, an estimated 785,000
Americans will have a new coronary attack and more than 50% will have a recurrent
attack [2]. Each year, it has been estimated that 195,000 patients will suffer from silent
first myocardial infarctions each year. Perhaps the most worrisome statistic is that it has
been approximated that every 25 seconds, an American will have a coronary event and in
every minute, someone will die of one [1].
The main disease contributing to these grave statistics is atherosclerosis, which is
global in distribution and is responsible for approximately half of the all deaths and
serious morbidity in the Western world [2]. Atherosclerosis is a chronic inflammatory
disease that is characterized by the development of intimal lesions in walls of arterial
blood vessels that is initiated by injury to the endothelium [3]. These lesions protrude into
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and obstruct vascular lumens and weaken the underlying media of the affected vessels.
The main cell types of the vasculature that are involved in the disease progression are the
endothelial cells in the intima and the smooth muscle cells in the media. The major
consequences of atherosclerosis are myocardial infarction, cerebral infarction, aortic
aneurysms and peripheral vascular diseases.
Severely narrowed and occluded atherosclerotic vessels are detectable by
angiography and the two main treatment options are coronary artery bypass grafting
(CABG) and percutaneous coronary intervention (PCI) [4]. During CABG, the diseased
vessel is bypassed with an autologous graft, preferably the saphenous vein or internal
mammary artery, to revascularize the tissue. CABG is an invasive procedure, requiring a
median sternotomy to gain access to the heart and also a secondary surgery to harvest the
autologous vessel for use as the graft, ultimately leading to an extended hospital stay and
long recovery period [4]. During PCI, or angioplasty, a cardiologist guides a deflated
balloon on a catheter from an incision in the inguinal femoral artery up to the site of
blockage in the heart. Real-time angiography and intravascular ultrasound (IVUS) are
used to locate the lesion and to accurately place the balloon loaded catheter and then the
balloon is inflated to open the occluded artery [4]. Next, a stent is often deployed at the
site of the blockage to maintain patency and blood flow. PCI is less costly and invasive to
the patient, when compared to CABG, and patients can often go home within a few days
and go on with their lives. Studies have shown that rates of major cardiac or
cerebrovascular events at 12 months were significantly higher in PCI patients when
compared to CABG patients (17.8% PCI vs. 12.4% CABG, p=0.002), due to increased
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rate of repeat revascularization for PCI patients when compared to CABG patients
(13.5% PCI vs. 5.9% CABG, p<0.001) [5]. However, at 12 months, the rates of death and
myocardial infarction were similar between the two groups, while stroke was
significantly more likely to occur with CABG (2.2% CABG vs. 0.6% PCI, p=0.003) [5].
Given these results, it can be seen that each procedure has a clinical need to make
improvements for improving the life of the patient.
For CABG procedures, autologous replacements are the gold standard, but are not
always readily available due to vascular disease or previous vessel harvesting [1]. They
are from the own patient (typically the radial artery, internal mammary artery, or the
saphenous vein), they are biologically based and have shown high long-term patency [2].
Complications associated with autografts include a secondary surgery site, inability to
tailor vessel dimensions, and limited supply. Unfortunately, it is common that patient
comorbidities prevent the use of autologous vessels. In this scenario, the surgeon has a
few options to choose from depending on the patient and preference. An allograft is a
vessel from another human that is decellularized and cryopreserved until needed, offering
a readily available and biologically based replacement with a long shelf-life [2].
However, risks include inability to tailor matrix contents, risk of viral transmission and
mechanical breakdown from processing. Another alternative is a xenograft, which is a
graft taken from another species, typically porcine. These grafts are readily available,
biologically based and have a long shelf-life. However, there is risk for immunerejection, the grafts often have to be modified and research has shown poor long term
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patency [2-4]. A summary of these biological grafts with clinical status are detailed in
Table 1.1.
Over 1 million procedures of coronary revascularization are performed annually
in the United States [5]. Due to the limited supply of autologous grafts, synthetic grafts
have been developed and are commonly used in the clinic. The two most commonly used
materials for synthetic grafts are polyethylene terephthalate (PET, trade name is Dacron)
and expanded polytetrafluoroethylene (ePTFE) [6]. Despite that ePTFE has been
observed to have lower platelet adhesion and complement activation, long-term patency
rates and performance are similar for ePTFE and Dacron [6]. Advantages of synthetic
grafts include being able to tailor dimensions for each patient and off the shelf
availability. W.L. Gore & Associates have been using a proprietary ePTFE blend, called
GORE-TEX, for vascular grafts, sutures, hernia meshes and endovascular repair.
Synthetic grafts have been used with success in large caliber vessels, but have shown
poor performance in small diameter applications due to compliance mismatch, thrombus
formation, infection and long term patency rates [7-9]. Autologous vein grafts usually
have between 60-80% patency after 5 years, while synthetic grafts have 45% standard
patency [6]. Further, these permanent prosthetic implants present the potential for a
lifetime risk of infection and thrombus formation. A summary of synthetic grafts and
their clinical status can be found in Table 1.1.
To address some of the issues associated with permanent synthetic grafts,
biodegradable polyesters and natural polymers are being developed with or without
recellularization of the graft (Table 1.1) [10]. Ahn and coworkers developed an
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electrospun poly(ε-caprolactone) (PCL) and collagen scaffold, combined with a smooth
muscle cell sheet, for a vascular graft [5]. The graft achieved high cell seeding efficiency
and a mature smooth muscle cell layer that expressed key vascular markers, like connexin
43, α smooth muscle actin, and myosin light chain kinase. Post-processing with a
pulsatile bioreactor demonstrated an increase in mechanical properties, when compared
to no conditioning (increases of 35.7% tensile strength, 47.5% elasticity and 113.2%
elongation) [5].
Tissue engineered approaches have been employed to address these shortcomings
and represent a means to fabricate functional vessel replacements capable of remodeling
to meet physiological and mechanical demands. Tissue engineering combines the
principles of engineering and life sciences in order to repair, restore and regenerate
tissues and organs that mimic the functionality and mechanical properties of native
tissues [11, 12]. In the United States, there are 121,000 people currently waiting for
lifesaving organ transplants (kidney, liver, heart) and tissue engineering offers new hope
and therapeutic opportunities for these patients, who might otherwise not receive the
treatment they need [13, 14]. The classic approach to tissue engineering involves seeding
living cells onto a solid biocompatible and eventually a biodegradable scaffold, and then
culturing the tissue engineered construct in a bioreactor until the tissue achieves the
desired cell density and mechanical properties (Table 1.2) for implantation [12]. For this
review, the focus will be on scaffold-free tissue engineering technologies (Table 1.1),
covering cell-sheet engineering, cell aggregates, bioprinting and magnetic force based
tissue engineering strategies.
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Table 1.1 Vascular Graft Technologies

Approach

Advantages





Disadvantages


Long Term Patency
Autologous Cell Sources
Allografts and
Xenografts Have Off the
Shelf Availability
Grafts Mimic Native
Tissue






Biological Grafts

Polymeric Grafts







Natural (Polymeric)
Scaffolds








Scaffold Free (SelfAssembly)









Readily Available
Tailored Dimensions
Potential for Controlled
and Safe Degradation in
the Body
Drug Delivery
Natural Origin of
Polymer (Elastin,
Collagen, Fibronectin)
Provides for Enhanced
Cell Attachment
Improved Tissue
Integration
Used In Combination
with Synthetic Polymers
Use of Autologous Cells
Control Over Structure
Purely Biological
Endogenous ECM
Produced
Potential for Automation
No Harsh Processing
Tissue Regeneration
Include Cell Sheet, Cell
Aggregate and
Bioprinting Technologies
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Clinical Status

Secondary Surgery for
Autografts with Limited
Availbility
Inability to Tailor Matrix
Risk of Viral
Transmission,
Immunorejection,
Thrombosis, and
Mechanical Breakdown
for Allografts
Risk of Immunorejection,
Poor Long Term Patency
and the Requirement of
Graft Modifications for
Xenografts



Mechanical Mismatch
Poor Performance in
Small Diameter
Applications
May Require
Endothelialization
Cost to Produce
Purification and Isolation
Poor Mechanical
Properties



Requirement of Large
Quantities of Autologous
Cells
Time of Fabrication
Tend to Have Poor
Mechanical Properties
and Require PostProcessing Conditioning













Autologous Grafts Are
the Gold Standard for
Vascular Grafts and Are
Used if Available
Vein Allografts Have
Been Used for Lower
Extremity and Coronary
Revascularization;
Decelled Allografts Have
Been Used in Animal
Models [15, 16]
ProCol and ArteGraft are
Xenografts Derived
From Bovine Mesenteric
Vein and Bovine Carotid
Artery, Respectively.
Clinical Trials Show
That They Are Safe
Alternatives to PTFE for
Hemodialysis Access
[17, 18]
W.L. Gore & Associates
Use a Proprietary Blend
of ePTFE for Vascular
Grafts and Aneurism
Repair [19, 20]
Poor Mechanical
Properties
High Processing Costs
Potential For Immune
Response

L’Heureux and
Coworkers Used Cell
Sheets and Have
Implanted in Humans for
Hemodialysis Access
(Cytograft) [21]
Niklason and Coworkers
Used Degradable
Polymers With
Autologous Endothelial
Cell Seeding. Grafts
Have Been Implanted in
Primates and Are
Awaiting Results of
Clinical Trials
(Humacyte) [22-24]

Table 1.2. Mechanical Properties of Native Blood Vessels

Vessel Type

Burst Pressure

Compliance

Suture Retention Strength

Arteries

3,196 +/- 1,264 mm Hg [25]

11.5 +/- 3.9 %/100 mmHg
[25]

138 +/- 50 gmf [25]

Veins

1680 +/- 307 mm Hg [26]

1.1 +/- 0.4 %/100 mmHg [27]

196 +/- 2 gmf [27]

1.2 SCAFFOLD-FREE TISSUE FABRICATION METHODS
Scaffold-based tissue engineering strategies have demonstrated precise control
over in-vitro microenvironments, which can provide the cues for directing the
development of tissues. However, issues with scaffold-based tissue engineering
approaches include degradation, mechanical mismatch, immunogenic responses and
unforeseen long term complications. While scaffold-based tissue engineering approaches
have seen significant advancements, scaffold-free tissue engineering approaches are
being heavily researched because the approach aims to develop tissues by taking
advantage of the natural self-assembly process observed in developmental biology [28].
Self-assembly is autonomous organization of tissue components (cells and ECM) from an
initial state into an organized structure without external intervention [29]. Without the
presence of an attachment surface or scaffold, cells will spontaneously aggregate and
undergo the process of self-assembly. Tissues have the innate ability to self-assemble,
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self-organize and ultimately regenerate under the proper conditions [12, 29-35].
Understanding these phenomena has led to new tissue fabrication methods, which
demonstrate high potential for clinical translation.
Advantages of scaffold-free technologies include no exposure of cells to harsh
processing requirements of scaffold-based constructs, the presence of a true biomimetic
environment with high cell communication, uninterrupted tissue remodeling, and no
degradation byproducts (Table 1.2) [35]. Even more, if scaffold-free technologies are
implanted in vivo, any mechanical forces will occur directly on the tissue, rather than
having the scaffold share the load. This will result in enhanced integration and maturation
of the tissue after implantation. One of the main limitations of scaffold-free technologies
is the poor mechanical properties associated with self-assembled tissues due to the
reliance on endogenous production of ECM over time [36, 37]. Post-processing methods
are being developed to address this issue and are based on providing mechanical and
chemical cues to the tissues that would be experienced by native tissues to accelerate the
maturation process [36, 38, 39]. Despite these advances, there has yet to be developed a
reliable method to produce custom ‘off the shelf’ tissues in a reproducible fashion using a
high throughput system, especially for the fabrication of tissues with multiple cell types.

Cell Sheet Approach
Cell sheet engineering involves constructing 3D tissues by layering 2D cell sheets
without any biodegradable alternatives for ECM [40-44]. The two main techniques use
either thermoresponsive poly(N-iso-propylacrylamide) (PIPAAm) polymer films coated
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on tissue culture plastic or special growth media conditions that stimulate ECM secretion,
thereby causing the cells to create a solid tissue sheet capable of manual manipulation
[26, 27, 41, 44]. Advantages of using cell sheet technologies are that sheets are that they
contain endogenously produced ECM and they can be spatial oriented with multiple cell
types to create a structurally correct tissue that can contain multiple cell types (Table
1.3). Disadvantages of cell sheet technologies include long culture time and the need for
post-processing techniques to enhance mechanical properties. Cell sheet technologies
have been applied to vascular tissues, myocardial patches, corneal reconstructions,
oesophageal, and dental tissues with demonstrated success in animal models [21, 27, 40,
41, 43, 45, 46].
Cytograft Tissue Engineering, founded by Nicolas L’Heureux, recently published
the results for the first human use of an allogenic tissue engineered vascular graft for
hemodialysis access [21]. Three allogeneic Lifeline grafts (Cytograft Tissue Engineering,
Inc, Novato, Calif) were implanted as the brachial-axillary arteriovenous (AV) shunts for
hemodialysis access. Results at the 6 month time point demonstrated a lack of
degradation and immunosensitization in all patients [21]. These findings indicate that
neither the transition to allogenic cells nor the change to a non-living graft adversely
affected the mechanical stability of the graft. While the clinical results are promising,
long fabrication times (6-9 months) and high autologous cell quantities required to
produce such grafts currently mitigates their widespread use. To address this issue, both
the fabrication times and cell quantities must be optimized prior to making such grafts
commercially viable [47].
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Humacyte, which was founded by Laura Niklason, is currently investigating the
use of allogenic SMCs to create a cell-derived acellular scaffold. Allogenic cells are
seeded onto a PGA scaffold and physically stimulated for two months to accelerate ECM
secretion and induce maturation using cyclic radial strain, followed by decellularization,
which results in a collagenous matrix. Bioengineered blood vessels were implanted as
end-to-end arterial and aterio-venous grafts in over 25 large animal studies, with no
evidence of hemodynamically significant intimal hyperplasia [24]. As of February 2014,
the bioengineered blood vessels are in clinical studies for hemodialysis use [24]. The
company aims to use this technology for vascular tissue engineering applications, as well
as patching damaged organs and tissues.

Cellular Aggregates
Scaffold-free cellular aggregates mimic the 3D orientation of native tissue and
produce and secrete their own extracellular matrix (ECM) [11, 29, 34, 48]. To produce
tissues using the aggregate method, a controlled amount of cells are dispensed and left to
spontaneously self-assemble over time. Methods to produce cellular aggregates include
suspension cultures, spinner flask cultures, pellet cultures and static cultures [49].
Aggregate technologies have been successful for vascular tissues when partnered with
non-adhesive molds, as tissue rings, toroids and tubes with measurable mechanical
properties have been fabricated [50-54]. The technology is advantageous because it
aggregates are biologically based, the fabrication time is short, aggregate composition
can be controlled and the addition of molds can provide control over tissue geometry
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(Table 1.3). Gwyther and coworkers used a circular agarose mold to fabricate SMCbased rings with inner diameters of 2, 4, and 6 mm [55]. Results demonstrated that
individual rings, as well as stacked rings to form tubes, could be fabricated in one to two
weeks in static culture [53]. Mechanical testing to quantify ultimate tensile strength
(UTS), stiffness, and toughness decreased (40% decrease in UTS in 6 mm rings) for each
sample as culture time increased due to necrosis in the core of the ring. The development
of a necrotic core in aggregate structures is a limitation that exists due to the lack of
vasculature for nutrient and waste exchange.
Morgan’s lab reported modeling fusion kinetics of hepatocyte tissue toroids over
time, which were fabricated from cell solutions seeded into agarose micromolds [50, 52].
Toroid lumen diameters were reproducible and thickness of toroids was controlled by
varying the cell density. Their work showed that these toroids could be stacked together
in order to undergo predictable fusion over time to form larger tissue structures, like
blood vessels [52]. Work from their lab also quantified the forces driving the selfassembly of toroids by measuring the upward movement of the tissues against gravity up
a cylindrical agarose pole [51].
Cellular spheroids have gained much of the spotlight recently because of their
potential to mimic tissues and organs on the micro scale [48, 49]. Spheroids with tissuespecific functions have been fabricated for cardiac, vascular, cartilage, bone, hepatic and
pancreatic applications, demonstrating their potentially broad impact for tissue
fabrication [49]. Due to this, spheroids have been investigated for use in building
vascular tissues, as well as for high throughput drug screening for pharmaceuticals. Kelm

11

and coworkers demonstrated that 3D spheroids have higher gene expressions over key
ECM protein genes responsible for functional tissues, like collagen, fibronectin, laminin
and matrix metallopeptidases when compared to 2D cultures [48]. Their group used
human artery-derived fibroblasts to fabricate small diameter tissue-engineered vessels
with spheroid building blocks. Assembled tissue constructs have been associated with
poor mechanical properties and require post-processing maturation techniques [56-58].

Bioprinting
Bioprinting is the automated, computer-aided, layer-by-layer deposition of cells
and cell aggregates for building three-dimensional biological structures [59, 60]. There
are two main techniques used, one being ink-jet printing and the other being technologies
that utilize mechanical extruders to deposit cells and materials. Ink-jet printing is a noncontact method that reproduces digital pattern information onto a substrate with tiny inkdrops composed of cells, ECM, biomaterials or a combination of the three [61, 62]. Here,
there are thermal, piezoelectric and electromagnetic approaches to create these drops on
demand. The thermal printers work by heating the printhead to generate air bubbles
which collapse to produce pressure pulses to eject ink drops of desired size on demand.
The size of droplet can be controlled by the temperature, frequency of the applied current
pulse and viscosity [63]. Piezoelectric printers work based on an actuator made from
polycrystalline piezoelectric ceramic, which provides pressure to eject ink drops onto the
substrate [63]. Burg and coworkers have been developed solutions to problems with
inkjet printing and are applying their technologies to tissue test systems, breast cancer
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models and biofabrication [64, 65]. Advantages of inkjet printing include versatility, low
cost, and rapid nature (Table 1.3). However, concerns arise with printing high cell
densities, high temperatures in the print heads damaging cells, and building in the ‘z’ axis
for larger 3D structures.
Mechanical extruders are another bioprinting technology that place precise
amounts of ‘bio-ink’ into supporting environments called ‘bio-paper,’ using computer
templates [28]. Bio-ink is usually composed of cellular spheroids, where the size, shape
and composition can be controlled. Bio-paper is a hydrogel that is typically composed of
agarose or collagen [29]. Here, multiple cell types can be incorporated, as well as
extracellular matrix. The spheroids are obtained by mechanically cutting uniform
fragments that spontaneously form into spheres due to tissue liquidity. These building
blocks can be matured by using non-adhesive molds. Next, the bio-ink can be deposited
into its location where post-processing steps that include fusion and cell sorting cause the
formation of organoids, or mini organs [29] . The advantage of this technology is that
these printed bio-ink particles represent 3D tissue fragments (Table 1.3). The bio-ink can
be deposited layer-by-layer with bio-paper to form complex 3D structures, however the
removal of the biopaper has proven to be a challenge. Jakab and coworkers have utilized
agarose rods and cylindrical multicellular building blocks, rather than collagen paper and
cellular spheroids to simplify this process [29, 32]. This bioprinting technique employs
developmental biology by allowing the tissues to self-assemble over time through fusion
and cell sorting. The disadvantage of this method is the high cost of the printers and
building thicker tissues that incorporate a vascular network. Organovo has developed a
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bioprinter, called the NovoGen Bioprinting TM Platform, and is applying it to fabricate
3D tissues for high throughput drug screening analysis [66]. Another company, called
Nano3D Bioesciences, demonstrated that they could construct 3D tissue models of breast
tumors. Preliminary studies using chemotherapy drugs, such as doxorubicin, suggested
that these 3D models might better model actual tumor response to therapeutics than 2D
cell cultures [66, 67].
At the moment, bioprinting is not yielding full-scale organs as imagined, but it
has allowed researchers to gain an understanding of how tissues develop and permitted
high-throughput screening on mini-tissues for drug screening. An interesting future
application proposed by Boland and collaborators is the idea of a hand held bioprinter
that can build implants and tissue replacements directly into the patient in the operating
room [62, 63]. Another developing technology is the use of magnetic forces to print cells
and tissues with incorporated magnetic nanoparticles [68, 69]. Regardless of the printing
technology used, the future use of bioprinting in the clinical relies on the successful
biofabrication of microvasculature.
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Table 1.3. Scaffold-Free Tissue Fabrication Methods
Approach

Technology

Advantages

Layer 2D Cell Sheets to
Create 3D Tissues Using
Temperature Sensitive
Culture Flasks or
Manual Manipulation






Cell Sheets





Relies On Cellular SelfAssembly and Fusion to
Create Larger Tissues



Cellular Aggregates



Bioprinting






Dispense and Pattern
‘Bio-Ink” Into Desired
Tissue Geometries
Using and Automated
‘Bioprinter’



Disadvantages

Biologically Based
Control Over Tissue
Spatial Orientation
Use of Autologous
Cells
Have Been Shown
to Yield Similar
Mechanical
Properties to Native
Vessels
Completed Clinical
Trials [21]



Biologically Based
Short Fabrication
Time
Control Over Tissue
Composition
Molds Provide for
Control Over
Geometry
Automated
Biologically Based
Rapid Fabrication
Precise Control
Over Tissue
Composition (bioink)
Control Over
Spatial Orientation

















Require PostProcessing
Techniques to
Enhance
Mechanical
Properties
Long Fabrication
Time
Time Required for
Adjacent Sheets to
Fuse
Not Automated
Require Large
Amounts of
Autologous Cells
Not Automated
Poor Mechanical
Properties
Require PostProcessing
Necrotic Core in
Thicker Tissues
Variable Cost
No Standardized
Printer
Instability With
Building in the ZAxis
Does Not Promote
Tissue Fusion
Poor Mechanical
Properties

1.3 CELLULAR SPHEROIDS IN TISSUE ENGINEERING
The classic approach to tissue engineering involves seeding living cells onto a
solid biocompatible and eventually a biodegradable scaffold, and then culturing the tissue
engineered construct in a bioreactor until the tissue achieves the desired cell density and
mechanical properties for implantation [12]. However, new approaches that build 3D
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tissues with a bottom up approach using cellular spheroids are offering new possibilities.
Rapid tissue fabrication approaches using spheroids have three key bioprocessing steps
that lead to the development of 3D tissue structures: (1) pre-processing, (2) processing,
and (3) post-processing.

Step One: Pre-processing
Pre-processing involves preparing the building block tissues that are used to
ultimately fabricate the 3D tissue. Here, cellular spheroids are the building blocks being
used as the ‘bio-ink.’ Spheroids are attractive for tissue fabrication techniques due to
having precise control over cell and extracellular matrix (ECM) composition, the ability
for upscaled production and repeatability, their three-dimensional nature and the fact that
spheroids will produce their own ECM over time. Spheroids with tissue-specific
functions have been fabricated for cardiac, vascular, cartilage, bone, hepatic and
pancreatic applications, demonstrating their potentially broad impact for tissue
fabrication. In addition to tissue engineering applications, spheroids are used in studying
cancer biology and also in pharmaceuticals with high throughput toxicology and drug
testing.
There are many pre-processing methods used to prepare cellular spheroids, which
include the pellet or re-aggregation culture, spinner culture, rotating wall vessels, cell
sheet techniques, liquid overlay, microfluidics, external forces, the hanging drop
technique, and micro-molded hydrogels [70]. The most popular spheroid pre-processing
methods are re-aggregation, hanging drop and micro-molds. In the re-aggregation
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method, cells from a confluent flask are collected and centrifuged down to form a cell
pellet in a tube [70]. This pellet can be removed from the tube, cut into fragments and
then incubated until they form rounded spheroids. In the hanging drop technique, small
volumes (15-30 μL) of cell suspensions are pipetted onto the lids of petri dishes [70]. The
lid is then inverted, with the drops staying attached due to surface tension. Gravity causes
the cell suspension to concentrate at the bottom of the droplet, forming a spheroid. Micromold pre-processing utilizes computer software for rapid prototyping of ‘templates’ for
creating micro-molds with an array of cylindrical pegs with rounded tops. These micromolds are then used to cast non-adhesive hydrogels into which cells can be seeded into.
Due to the non-adhesive surface, the cells will aggregate and form a spheroid.
Spheroids can be fabricated with a either single or multiple cell types, which
demonstrates the potential for fabricating many types of tissues. Even more, endothelial
cells can be co-cultured with other cell types, like smooth muscle cells, to create
uniluminal spheroids [71]. This is important for tissue engineering because it highlights
the potential for using uniluminal vascular spheroids as modules for fabricating blood
vessels. ECM proteins, like collagen or fibronectin, can be incorporated into cellular
spheroids to promote cell-matrix interactions and provide an early structural network for
the developing spheroids. Magnetic nanoparticles (MNPs) have also been incorporated
into cellular spheroids to allow for the ability to pattern and align the spheroids for tissue
assembly. This pre-processing development has allowed for tissues to be manipulated
with physical magnetic forces at a distance in the processing step and has potential for
being used for maturation techniques.
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Millions of tissue spheroids will be required for organ fabrication [69]. High
throughput methods for spheroid fabrication have been developed for biological research,
therapeutic testing and 3D tissue construction [72-74]. Micro-mold arrays are leading this
thrust, with hanging drop and round-bottom well plate designs for fabricating up to 384
spheroids per standard 96 well plate. The use of these approaches, partnered with a
robotic dispenser increases the productivity of spheroid biofabrication [69]. After
formation, spheroids can be stored in bio-cartridges (micropipettes) for dispensing in the
processing step, or stored in cell culture medium for a desired incubation period.
Preventing unwanted fusion of stored tissue spheroids will be challenge that develops
with upscaling spheroid fabrication.
Ultimately, the pre-processing step allows for customization of the spheroid for
specific applications because of the control over cell type, size, and ECM content. Given
this precise control over composition and their versatility, spheroids are a desirable
candidate for the pre-processing step in rapid fabrication of tissues.

Step Two: Processing
The processing step involves dispensing the cultured spheroids into the desired
geometry, one layer at a time. This step is critical because a bioprocessing technique is
required to take individual spheroids and position them on a suitable substrate for tissue
formation. In this processing step, the spheroids can be dispensed into a ‘bio-paper,’
which is a biocompatible hydrogel sheet that provides a non-adhesive surface for the
spheroids to be printed on [11, 59, 75]. The bio-paper has been mimicked after the natural
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ECM and contains the minimal composition for cell attachment, growth and maintaining
tissue liquidity for permitting fusion of the spheroids. Crosslinked agarose and gelatin
have been shown to function well as the bio-paper, as both provide the required nonadhesive surface for the tissues to be printed onto [59]. The bio-paper can also be molded
into desired geometries with a peg and circular well, which allows tubular structures to be
formed. Standard non-treated, non-adhesive polystyrene plates are used for culturing
spheroids long term, as well as assembling tissues [76-78]. Ideally, the bio-paper should
mimic the stiffness of the tissue being fabricated.
In order to dispense spheroids for patterning and alignment, robotic pipette
dispensers, like the EpMotion-5070 (Eppendorf), have been developed [69].
Developments in rapid prototyping technologies has allowed for robotic bioprinters to be
able to continuously dispense spheroids using x-y-z precise robotic position, automated
spheroid dispensers, and computer based software [69]. While these devices have been
shown to successfully pattern the spheroids, these devices have issues when building
tissues up in the z direction without the use of a mold. Bioprinters are usually custom
built, based on the need of the laboratory, and have not yet been standardized in industry.
Given this, as lot of tissue assembly is ‘done by hand’, meaning the spheroids are
dispensed into the biopaper or molds in a non-automated fashion using a pipette. To
‘build’ tissues, spheroids can be dispensed on top of each other in a layer by layer fashion
on a biopaper using a bioprinter, spheroids can be dispensed into molds and plates with
predefined geometries, or magnetically labeled spheroids can be patterned and aligned
using magnetic fields [69, 76-78].
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After the spheroids have been patterned and aligned into the desired geometry,
passive contacts from cell-cell and cell-matrix interactions will cause the spheroids to
fuse together to reduce configurational energy. Fusion occurs when adjacent spheroids
make contact and coalesce into a cohesive tissue, and this is an essential process for
tissue maturation. Macroscopically, individual spheroids should no longer be visualized
in a fused tissue. While bioprinters and micro-mold designs create passive contact
between spheroids, they do nothing to accelerate spheroid fusion, which is critical for
tissues manipulation during maturation. Recently, magnetic fields have been used as a
physical force to accelerate the fusion process with active contacts by increasing cell-cell
and cell-matrix interactions in magnetic cellular spheroids [78]. Mattix and coworkers
demonstrated that magnetic cellular spheroids whose fusion was mediated by magnetic
forces produced a more cohesive and homogenous tissue at earlier time points, when
compared to control spheroids without magnetic forces. The use of magnetic forces for
accelerating the fusion of magnetic cellular spheroids is a critical improvement because
these fused tissues can be introduced into post-processing methods for maturation at
earlier time points than previously.

Step Three: Post-processing
The post-processing step involves using bioprocessing techniques for promoting
tissue maturation. Tissues fabricated with spheroids are often associated with poor
mechanical properties. Increasing the synthesis, deposition, cross-linking and assembly of
ECM is critical for accelerating the maturation of fused tissues because it develops the
dense structural network that translates to tissue strength [11, 75].
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To accelerate the maturation of fused tissues, bioreactors have been designed to
simulate in vivo conditions and provide the necessary chemical and mechanical cues
experienced by native tissues. Some key characteristics of bioreactors include being able
to: (1) control the environment during mechanical stimulation; (2) stimulate multiple
constructs with identical or individual waveforms; (3) deliver precise displacements,
including those that mimic in vivo activities of daily living; and (4) adjust displacement
patterns based on reaction loads and biological activity [79]. Bioreactor types include
spinner flask bioreactors for cell seeding on 3D scaffolds, rotating wall vessels for
providing a dynamic culture environment with low shear and high mass transfer, hollowfiber bioreactors for enhancing mass transfer during culture of highly metabolic and
sensitive cell types, direct perfusion bioreactors for to have medium or cell solutions flow
throughout a tissue or scaffold and bioreactors that provide controlled mechanical forces
to the tissue [80].
Utilizing controlled mechanical forces has become the most popular for rapid
fabrication techniques because mechanical methods offer the ability to deliver
mechanical cues that tissues experience in the physiological setting. Mechanical forces
used to induce maturation include pulsatile radial strain, longitudinal stretch, pulsatile
flow, and compression [56, 80-84]. These forces can be precisely controlled and
generated using software, like LABVIEW, paired with stepper motors, pumps and
actuators. Mechanistic variables include frequency, magnitude, time per day of
stimulation, and total days of stimulation. Research has shown that these mechanical
methods have successfully accelerated tissue maturation in terms of ECM deposition and
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increased mechanical properties for tissues based on cell sheet technologies and collagen
gel tissue constructs [56, 81, 83]. Cyclic radial stretching and pulsatile flow have been
shown to enhance ECM production (collagen and elastin) and enhance mechanical
properties of tissue engineered blood vessels, but the parameters for optimal maturation
(frequency, magnitude, time of stimulation) have not been defined [56, 57, 82, 83, 85].
Both static and dynamic longitudinal stretch of tissue sheets have accelerated
extracellular matrix deposition and rapidly improve mechanical properties, both of which
are critical for the development of a suitable tissue engineered replacements [81, 86].
Recently, magnetic forces have been investigated for mechanical conditioning
with ‘action at a distance.’ By taking advantage of cells and ECM tagged with MNPs,
RT-PCR results showed that dynamic magnetic forces (1 hr/day, 1 wk, 1 Hz) led to
upregulation of osteocalcin, osteopontin and alkaline phosphatase in human bone cells,
when compared to controls [87]. Using magnetic forces for maturation offer several
advantages: (1) precise control of physical stresses through variation of the magnetic
force; (2) the MNPs are remotely coupled to a magnet array with no components
connected inside the bioreactor, reducing potential contaminations; (3) magnetic arrays
are scalable and present the opportunity to apply varying load profiles via particles and
magnets of differing magnetic properties [87].
Despite advances in tissue maturation, standardized methods have not been
developed for large scale applications and a challenge remains for understanding what
mechanisms drive in vitro tissue maturation.
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Current Challenges in Pre-processing, Processing and Post-Processing of Spheroids
Poor mechanical properties, a lack of understanding fusion and maturation
mechanisms, and the absence of engineered vascular networks creates uncertainty for
fabricating viable and functional engineered tissues and organs. While long term viability
of individual spheroids has been confirmed up to 7 weeks, the long term viability of
larger tissues composed of spheroids is of concern due to the need for a method of
nutrient and waste exchange with increasing tissue depth [78]. The ideal cell number and
ECM content of spheroids for rapid tissue fabrication has not been elucidated and will
likely be dependent on the application. A typical tissue engineered construct requires 107
to 109 cells, which means upscaling and automating spheroid production is required to be
able to fabricate tissues and organs [11, 69].
Understanding and accelerating the fusion of spheroids is essential for the success
of tissue fabrication. High throughput testing of maturogenic factors on fusing spheroids,
as well as studying the influences of cell number and ECM content on fusing spheroids is
providing quantitative data for understanding the mechanisms of this maturation process
[39]. Work by Hajdu and coworkers demonstrated that tissue spheroids incubated with
maturogenic factors, TGFβ1 and serotonin, were more cohesive than control spheroids
and on average were enveloped 40% by untreated spheroids, versus 10% by control
spheroids [39]. Results also showed that these maturogenic factors had increased levels
of collagen production as exhibited by increased immunofluorescent levels of Hsp47, a
known intracellular chaperone of collagen types I-IV [39].
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Magnetic forces have successfully been used to align magnetic cellular spheroids
and accelerate their fusion by promoting active contacts between cells [76-78]. This
technology has promise in developing technologies because physical forces generated by
the magnetic field are able induce maturation without coming into contact with the tissue.
Currently, mechanical post-processing methods for maturing fused spheroids are
in the early stages of development. Obtaining measurable mechanical properties of fusing
and maturing tissues over time will lend insight for optimizing post-processing
maturation techniques. Ideally, engineered tissues should contain the necessary cell types,
ECM content and mechanical properties that would be required for functionality in vivo.
Rapidly fabricated tissues should be available for use after maturation, or be stored long
term for future needs. Preventing the unwanted fusion of spheroids stored for long term
use must also be addressed.
The pre-processing, processing and post-processing steps in rapid tissue
fabrication with spheroids have limitations that require improvements. Upscaled spheroid
production, accelerating the fusion of spheroids with magnetic forces and improvements
in bioreactor design give promise for using spheroids in rapid tissue fabrication. These
emerging bioprocessing techniques must meet regulatory requirements that will emerge
from their development to ensure their safety and efficacy in clinical applications. The
lack of an engineered vascular network is the limiting factor in building tissues and
organs with spheroids and must be addressed moving forward.
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1.4 MAGNETIC FORCE BASED TISSUE ENGINEERING
Magnetic nanoparticles (MNPs) are now being increasingly used in biomedical
applications, with some FDA approved iron oxide MNP formulations used to treat iron
deficiency (Feraheme) or as MRI contrast agents (Feridex) MNPs have been investigated
in tissue engineering applications for in vivo cell tracking, in vivo monitoring of
transplanted tissues, cell and tissue patterning, and tissue maturation [88-97]. The
prolonged presence of these nanomaterials within biological systems remains a concern
due to potential adverse effects on cells, which is caused by toxicity and undesired
changes in cell phenotype [90, 98-100]. Though the surface functionalization or coating
of MNPs in oleates, dextran, or polymers can improve MNP biocompatibility, they do not
control the MNP degradation [101-106]. Accelerating the degradation of nanomaterials
within biological systems is expected to reduce the potential adverse effects in the tissue.
A variety of different chemicals, primarily organic acids, have been investigated to
accelerate the degradation of iron oxide MNPs [107-112]. Mattix and coworkers reported
the precise control of iron oxide MNP degradation via MNP encapsulation within
biodegradable polymers for tissue engineering applications [77]. Similar to biodegradable
polymeric scaffolds, the ideal nanomaterial will remain stable for a sufficient amount of
time to accomplish its desired task, and then rapidly degrade once that task is completed.

Magnetic Nanoparticles in Tissue Engineering
Magnetic assembly is attractive for tissue engineering applications because it
allows for manipulation and patterning from a distance with magnetic fields [113]. A
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variety of methods that utilize internalization of MNPs into cells have been investigated
to integrate MNPs with tissue engineering, including MNP conjugation/binding to the
cell [89, 92, 93], cellular internalization [98, 114-116], and mixing MNPs within the
ECM [88, 114, 117]. Practically speaking, having dark magnetic nanoparticles make
tissue visualization and imaging easier. Cells labeled with iron oxide MNPs have been
transplanted into rats and tracked over time using MRI (Table 1.4) [118]. In vitro studies
have shown that labeled cells partnered with magnetic forces enhanced cell seeding on
tissue engineered constructs [119]. Further, magnetic forces have been used to improve
upon current scaffolding technologies, as Bock and coworkers have developed a
magnetic scaffold to which growth factors or other biologically active molecules bound
to magnetic particles can be delivered on demand by means of an externally applied
uniform magnetic field [120]. However, all of these approaches are limited to short term
studies due to adverse effects related to MNP internalization [88-90, 116, 121] into cells.
One particular concern for vascular tissue applications is the unwanted activation of
endothelial and smooth muscle cells by nanoparticles over time [119]. This can lead to
downstream intimal hyperplasia, which compromises vessel patency.
A novel method to incorporate iron oxide magnetic nanoparticles into cellular
spheroids was developed, called the Janus method, and this technology is innovative
because upon spheroid fabrication, two separate domains are created: cells and MNPs
[37, 76-78, 122]. The limited interaction between cells and MNPs allows high viability
and phenotypic expression to be maintained over time, which is essential for tissue
engineering applications. MNPs can also be incorporated into spheroids using the
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dispersed and uptake methods. The dispersed method distributes MNPs throughout the
spheroid, while uptake spheroids are fabricated from cells that have previously
internalized MNPs [78]. Bratt-Leal and coworkers developed a method to entrap MNPs
into the extracellular space of stem cell spheroids using PDMS microwells and
centrifugation [123]. Advantages of incorporating MNPs into tissue spheroids include
manipulating and aligning spheroids into desired patterns for tissue engineering
applications without adverse effects on viability or phenotype (Table 1.4) [36, 37, 76,
113, 122, 124]. Further, tissues composed of magnetic cellular spheroids can be matured
using magnetic forces during post-processing steps. Spheroids composed MNPs have
been used to fabricate a tissue tube composed of endothelial cells, smooth muscle cells
and fibroblasts with controlled spatial orientation as a proof of concept for engineered
vasculature [78]. Recently, Olsen and coworkers studied the influences varying spheroid
composition on the fusion of vascular spheroids mediated by magnetic forces and also
demonstrated that spheroids containing iron oxide magnetic nanoparticles produce more
collagen over time when compared to no iron oxide controls [37]. Concerns with this
technology include the development of a necrotic core due to diffusion limitations,
understanding the influences of MNPs on ECM production, the requirement of large
quantities of cells and the need for post-processing maturation of tissues composed of
spheroids because of poor mechanical properties [2, 37].
Magnetic cellular sheets have been fabricated and contain cells, ECM and MNPs
[91, 125]. Typically, MNPs are incorporated into the cell sheets using uptake and
internalization of the particles. The technology is advantageous because 2D sheets can be
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layered to form 3D structures, magnetic forces can be used to wrap the sheets around
tubes for vascular applications, and these tissues can potentially be stimulated using
magnetic forces for maturation (Table 1.4). Ito and coworkers used this approach to wrap
a magnetic cell sheet around a magnetic mandrel and assembled multicellular tissue tubes
[126]. However, this method induced internalization of MNPs into cells prior to cell
sheet assembly and will likely encounter adverse effects related to MNP uptake in longterm applications [98, 127].
Table 1.4. Magnetic Nanoparticles and Magnetic Forces in Tissue Engineering
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Post-Processing Maturation Using Magnetic Forces
Magnetic forces are now being employed to induce maturation of MNP labeled
tissues by applying mechanical forces directly to the particles contained within the cells
and tissues. This technology is advantageous because tissues can be stimulated with
action at a distance, with controlled frequency, magnitude, strength of field and time of
stimulation (Table 1.4) [87, 128, 129]. Further, the technology can be automated, which
can allow for multiple load profiles to be tested using this scalable technology. To
improve upon this developing technology, there needs to be a deeper understanding on
the influence of MNP stimulation by magnetic forces in tissues over time, the optimal
magnetic force conditions need to be developed for tissues of interest, there needs to be
some sort of standardized system and finally, with any developing technology, cost for
development is a concern [129].
Thus far, magnetic forces have been used to mature bone constructs [130-132].
Magnetic particle-labeled human bone marrow stromal cells (HBMSCs) encapsulated
into alginate chitosan capsules were exposed to magnetic forces both in vitro and in vivo
intermittently for 21 days [130]. A pulse magnetic conditioning bioreactor was used with
1 Hz frequency and 1 hour of stimulation per day. After 21 days the encapsulated,
magnetic particle-labeled HBMSCs in vivo were viable as evidenced by extensive cell
tracker green fluorescence. The mechanical stimulation of HBMSCs labeled with TREK1 magnetic nanoparticle receptors enhanced expression of type-1 collagen in vitro with
increases in proteoglycan matrix, core binding factor alpha1 (Cbfa1) and collagen
synthesis, and extracellular matrix production and elevated the expressionof type-1 and
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type-2 collagen in vivo. Additionally, the magnetically remote stimulation of HBMSCs
labeled with magnetic nanoparticle arginine–glycine–aspartic acid considerably enhanced
proteoglycan and collagen synthesis and extracellular matrix production and elevated the
expression of type-1 and type-2 collagen in vivo and in vitro [130].
Another interesting application of magnetic forces for maturation purposes is the
delivery of biological agents on demand. Zhao and coworkers developed a macroporous
ferrogel scaffold that can be remotely controlled by a magnetic field to deliver various
biological agents on demand [133, 134]. The active porous scaffold gives a large
deformation and volume change of over 70% under a moderate magnetic field. Under
applied magnetic fields, the macroporous ferrogel gave large and prompt deformation,
causing water flow through the interconnected pores. The resulting deformation and
water convection was shown to trigger and enhance the release of biological agents in a
mouse model [133].
Sapir and coworkers investigated the potential use of magnetic forces to develop
vessel like structures in alginate scaffolds [135]. Magnetite-impregnated alginate
scaffolds seeded with bovine aortic endothelial cells were stimulated during the first 7
days out of a total 14 day experimental course and showed significantly elevated
metabolic activity during the stimulation period. Samples were stimulated using an
externally applied alternating magnetic field with a frequency of 40 Hz and strength of
10-15 Oe. Expression of proliferating cell nuclear antigen (PCNA) indicated that
magnetically stimulated cells had a lower proliferation index as compared to the nonstimulated cells. This suggests that the elevated metabolic activity could instead be
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related to cell migration and re-organization. Immunostaining and confocal microscopy
analyses supported this observation showing that on day 14 in magnetically stimulated
scaffolds without supplementation of any growth factors, cellular vessel-like (loop)
structures, known as indicators of vasculogenesis and angiogenesis were formed as
compared to cell sheets or aggregates observed in the non-stimulated (control) scaffolds
[135].
As it can be seen, magnetic forces are being increasingly used in tissue
engineering applications due to the unique capabilities of the technology. Exciting
aspects are that no special mediums, scaffolds, matrices or molds are required for
magnetic forces based tissue engineering. The technology is simple, flexible and has been
shown promising results for drug screening, tissue fabrication, stem cell research and
regenerative medicine. Ultimately, magnetic force based tissue engineering will have to
be compared side-by-side with other tissue fabrication methods to determine its true
value for future use.
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CHAPTER 2
HISTOLOGICAL EXAMINATION OF JANUS MAGNETIC CELLULAR SPHEROIDS
2.1 INTRODUCTION
Tissue engineering uses knowledge of biology, material science, biochemistry,
engineering and physiological systems to replace or repair damaged, diseased or lost
tissues in the human body with functional tissue that mimics native tissue. One of the
biggest challenges in the field of tissue engineering is the in vitro fabrication of
functional tissue engineered constructs with high cell density, high cell viability and an
extracellular matrix (ECM) network that mimics native tissue. Cellular spheroids are
composed of cells and the extracellular matrix (ECM) that they produce, and are
extensively used in basic science, developmental biology, cancer biology, tissue
engineering, drug discovery and toxicity testing. When compared to two dimensional in
vitro cell cultures, three dimensional cell cultures are being investigated as building
blocks for scaffold-free tissue engineering applications due to their ability to mimic the
native cellular and ECM environment of natural tissues [36]. More recently, spheroids are
being developed for use as tissue building blocks for rapid tissue fabrication in
regenerative medicine. Achieving high cell densities, developing a network of ECM and
maintaining high cell viability are necessary for the fabrication of functional tissue
engineered constructs.
Spheroids can be fabricated with one cell type, or co-cultured with other cell
types, which is desirable for fabricating tissue types with varying complexities and
functionalities[30, 59]. Tissue assembly and fabrication methods include 3D printing, cell
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sheet techniques, and patterned molds [11, 26, 29, 32, 62, 136]. These methods assemble
the spheroids or cells into a desired position through passive contact, but do not
encourage active contact mediated by forces to promote fusion of the tissue over time.
This can cause issues with tissue inhomogeneity, geometrical defects and increases in
fabrication time. Our lab has developed the Janus magnetic cellular spheroid (JMCS)
structure to safely incorporate iron oxide magnetic nanoparticles (MNPs) into cellular
spheroids [2, 76-78]. This method allows for spatial control over MNPs to form two
distinct domains: cells and extracellular matrix. Safely incorporating MNPs allows for
utilizing magnetic forces at a distance to pattern JMCSs into desired geometries for
building larger, more complex tissue constructs such as rings, spheroid sheets and tubes
for various tissue engineering applications[78].
With an increasing use of spheroids in tissue engineering applications, it is critical
to understand and visualize cellular and structural changes in developing spheroids and
tissues composed of spheroids over time. While histological stains have been developed
and standardized to meet these needs, a challenge remains in the preparation of cellular
spheroids for histological sectioning and examination. The size of spheroids used for
tissue building blocks ranges from 200-500 µm and this depends on the cell number used
[70]. The small size of spheroids presents challenging methodologies for histological
preparation. Conventional histological processors are not recommended to process
spheroid anatomic qualities and preserve morphological properties. Preparing research
samples with conventional standard processing methods can increase opportunity for
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delicate samples to dissipate or increase degradation. Manually processing samples
enhances spheroid survival and continuation of research.
Further, it is critical to understand and visualize the fusion and maturation of
tissues composed of JMCSs over time. To understand these mechanisms, studies must
include analyzing phenotypic expression, visualizing the spatial orientation and viability
of cells, studying extracellular matrix organization and localizing iron oxide magnetic
nanoparticles throughout the developing tissues over time. Tissue stains, such as the
hemotoxylin and eosin (H&E) stain, the Masson’s Trichrome stain, the Verhoeff-Van
Gieson stain, Turnbull’s Blue Reaction stain, and immunohistochemical stains have been
developed for these purposes. While histological examination allows for analysis of the
tissues composed of spheroids, preparing and processing these tissues for staining and
analysis is challenging. It is not recommended to use conventional histological processors
or standard processing methods, due to the delicacy of the samples, which makes it
necessary to use manual processing to increase the survival of the samples and preserve
tissue morphology. Here, we report the techniques developed in our lab used for
preparation of spheroids and tissues composed of spheroids for manual histological
examination.

2.2 MATERIALS & METHODS
An overview of experimental procedures, parameters, and objectives can be found
in Table 2.1.
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Table 2.1. Manually Processing Spheroids and Tissues Composed of Spheroids for
Histological Examination. A method was developed to manually process spheroids and
tissues composed of spheroids for histological examination, while preserving tissue
morphology. Processed samples were sectioned and stained using a Hemotoxylin and
Eosin stain, Masson’s Trichrome stain, LIVE/DEAD stain and immunofluorescence
staining.

Cell Culture
Primary rat aortic smooth muscle cells (SMCs) were used for all studies. All cells
were cultured in monolayer cultures at 37 °C and 5% of CO2 until spheroid assembly.
SMCs were cultured using Dulbeco’s Modified Eagle Medium: F-12 (ATCC, 1:1,
DMEM: F-12) supplemented with 10% fetal bovine serum (Atlanta Biologics, Miami,
Florida) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc., Manassas,
Virginia).

Spheroid Assembly
Spheroids were prepared using a method developed in our lab and previously
described [36, 37, 76-78]. Our lab developed the Janus structure of magnetic cellular
spheroids (JMCS), which provides spatial control of MNPs to form two distinct domains:
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cells and extracellular MNPs [78]. No Iron Oxide (NIO) spheroids are fabricated without
iron oxide MNPs. Equal volumes of solutions containing suspended iron oxide MNPs
(Fe3O4, 20-30 nm, SkySpring Nanomaterials, Inc., Houston, Texas), collagen (Bovine,
Type I, Life Technologies, Carlsbad, California), and cells in cell culture media were
combined and dispensed to form spheroids. Collagen, Type I was prepared according to
the manufacturer recommendations and kept on ice prior to use for all samples.
Formulations calling for no iron oxide were replaced with an equal volume of media.

Fabrication of Tissue Rings
Rings composed of JMCSs were assembled using ring magnets (2 mm outer
diameter, 1 mm inner diameter, 1 mm thick, vendor calculated pull force = 0.16 lbs,
SuperMagnetMan Inc., Alabama, USA) (Figure 2.1A). The magnets were attached to the
bottom of glass chamber slides containing cover glass bottoms. The wells were filled
with cell culture media and 25 individual JMCSs of the same formulation (same cell
number, ECM concentration and iron oxide MNP concentration) were carefully patterned
in a monolayer around the magnetic ring using pipette tips. The rings were incubated at
37°C and 5% CO2 for 48 hours to allow fusion to occur, after which the magnets were
removed. This was found to be the minimum time required to manipulate the rings, while
keeping them intact.
Fabrication of Tissue Sheets
Sheets composed of JMCSs were assembled using a strip of magnets (2.5 mm
outer diameter, 5 mm length, K&J Magnetics, Inc., Pennsylvania, USA) (Figure 2.1B).
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Five magnets were attached to the underside of a 6 well plate (Greiner Bio-One, North
Carolina, USA) and a glass cover slip (micro cover glass 22x30 mm, VWR,
Pennsylvania, USA) was positioned directly over the magnets within the well plate to
prevent spheroid adherence to the well plate. The wells were filled with cell culture
media and 1,000 JMCSs were carefully aligned on the coverslip using a pipette tip and
incubated at 37°C and 5% CO2 for 3 days to allow fusion to occur. Three days was found
to be the minimum time required to manipulate the tissue sheets while preserving
morphology. To remove the tissue sheets, a sterile pipette tip was used to gently scrape
the sample off the surface of the glass so that it could be collected for processing.

Fabrication of Tissue Tubes
After 3 days, fused tissue sheets composed of JMCSs on glass cover slips were
removed from the 6 well plate. Next, fused tissue sheets were wrapped around a silicone
tube (5 mm outer diameter, 2.5 mm inner diameter, Cole-Parmer, Illinois, USA)
containing a magnet (2.5 mm diameter, 5 mm length, pull force = 1.8 lbs,
SuperMagnetMan Inc., Alabama, USA) within its lumen to effectively wrap the sheets
around the tube (Figure 2.1C). To avoid oxidation of the magnet by culture media, the
ends of the silicone tube were plugged with silicone rubber. Samples were incubated in
culture medium at 37˚C and 5% CO2 for 7 additional days. This was found to be the
minimum time required to manipulate the tissue tubes without them breaking apart upon
removal

of

the

sample

from
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silicone

tube.

Figure 2.1. Magnetic Force Assembly for Fabrication of Tissue Rings, Sheets and
Tubes. To study the fusion of JMCSs, spheroids were magnetically patterned into various
geometries to represent various tissue engineering applications. A schematic for the
magnetic patterning of tissue rings (Figure 2.1A), tissue sheets (Figure 2.1B) and tissue
tubes (Figure 2.1C) is shown with pictures of each respective tissue after fabrication.
(Scale = 500 μm).
Spheroid Fixation, Processing, Embedding and Sectioning
Spheroids were collected and individually placed into 0.65 mL conical tubes with
150 µL of Z-Fix (buffered zinc formalin, Anatech Ltd., Battle Creek, Michigan) for
overnight fixation. Samples were allowed to settle to the bottom of tubes via gravity. The
following day, the Z-fix was removed and the spheroid samples were dehydrated using a
series of ethanol and xylene incubations (Table 2.2). For ethanol solutions, deionized and
distilled water was used for dilutions. Our lab works with spheroids that incorporate iron
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oxide MNPs, making visualization of the spheroids easier. However, spheroids composed
of just cells and ECM are often difficult to visualize because of the white/clear color of
cells and ECM. After the second 100% ethanol step, spheroids were transferred using a
pipette to individual embedding molds filled with xylene. This step is critical because
once the spheroid is in xylene, visibility of spheroids with just cells and ECM becomes
very poor, so this ensures that these samples makes it to the embedding molds. After
incubating the samples in xylene, this solution is carefully removed using a pipette
(without removing the cellular spheroid) and replaced with molten paraffin for overnight
infiltration of the samples. Samples were incubated with molten paraffin overnight at
56˚C.
The next day, the embedding molds were filled with molten paraffin and the
cellular spheroids were oriented to the center of the mold for ease of sectioning. Each
embedding mold containing a spheroid sample was then covered with a numbered
embedding block holder and placed on a cold plate at -4˚C for at least 1 hour prior to
removal of the embedding mold. 5 µm thick microtome cuts of spheroid samples were
taken. Microtome cuts were floated on a water bath and placed on a glass histology slide.
For further review at both macroscopic and microscopic levels, each slide was visually
examined grossly and under a microscope to ensure that spheroids were fully intact
(analyzed for tears, rips or sample irregularities). The slides containing the samples were
incubated overnight in a 65˚C oven to dry and remove excess paraffin.

Tissue Fixation, Processing, Embedding and Sectioning
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Ring tissues composed of JMCSs were left in their well plates and the cell culture
media was removed and replaced with Z-Fix for overnight fixation (buffered zinc
formalin, Anatech Ltd., Missouri, USA) for overnight fixation. Tissue sheets were left in
their well plates and the cell culture media was removed and replaced with Z-Fix for
overnight fixation. The tissues were left in their respective well plates and the magnets
were left in place for overnight fixation to prevent any issues that could arise from
handling the tissues and to preserve tissue morphology. Tube tissues were left on the
silicone mandrel and placed into a glass vial to be submerged in Z-Fix for overnight
fixation. The tissue was left wrapped around the silicone mandrel and the magnet left in
the lumen for overnight fixation in order to preserve tissue morphology.
After overnight fixation, the Z-Fix was removed and the tissue samples were
dehydrated using a series of ethanol and xylene incubations (Table 2.2) [137].
Immediately prior to the first ethanol incubation, the tissue tube was removed from the
silicone mandrel. Given that our lab has done extensive histological examination of
spheroids, a protocol was developed for preparing and processing these individual
spheroids. However, since the tissue rings, tissue sheets and tissue tubes are larger, more
complex and composed of many spheroids, the times for the ethanol incubations were
doubled to ensure proper infiltration. For ethanol solutions, deionized and distilled water
were used for dilutions. The times selected for incubation were chosen in accordance
with literature values with automated and manual processing [138]. The times used for
incubation are also comparable to what automated tissue processing programs regularly
use (SAKURA Tissue TEK VIP) for standard tissue processing. After incubation in
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xylene, the solution was removed and replaced with molten paraffin (Surgipath EM-400,
56°C, Leica, Illinois, USA) using a Tissue-Tek TEC Tissue Embedding Console System
(Sakura, California, USA). Samples submerged in molten paraffin were placed in one of
the thermal chambers of the embedding console for overnight infiltration of paraffin at
60˚C.
Table 2.2. Protocol for Fixing and Processing Spheroids and Tissues Composed of Janus
Magnetic Cellular Spheroids
Step

Reagents

Time for Spheroids

Time for Tissues

1

Z-Fix

Overnight

Overnight

2

70% Ethanol

15 minutes

30 minutes

3

80% Ethanol

15 minutes

30 minutes

4

95% Ethanol

15 minutes

30 minutes

5

95% Ethanol

15 minutes

30 minutes

6

100% Ethanol

15 minutes

30 minutes

7

100% Ethanol

15 minutes

30 minutes

8

Xylene

10 minutes

15 minutes

9

Molten Paraffin

Overnight

Overnight

After overnight incubation in molten paraffin, tissue samples were transferred to
appropriately sized embedding molds filled with molten paraffin. Here, care was taken to
properly orient the tissues in the center of the mold for ease of sectioning. The embedding
molds were each covered with a numbered embedding block holder and placed on a cold
plate at -4°C for at least 1 hour. Following, the molds were removed and embedded tissue
blocks were placed in an ice water bath for 10 minutes in order to rehydrate the tissue
samples for ease of sectioning. A microtome was used to cut 5 μm thin sections from the
tissue samples. These sections were suspended on the surface of a heated deionized water
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bath (44˚C) and placed on a silanized glass histology slides (Adhesive Coated Slides,
New Silane White Frosted, Newcomer Supply, Wisconsin, USA), due to the delicacy of
the tissue samples[139]. Each slide was visually examined under a microscope to see if
the sample was observed and to check for tears, folds or irregularities of the sample. The
slides containing samples were incubated overnight in an oven (65°C) to remove excess
paraffin.

Hematoxylin and Eosin Stain
The Hematoxylin and Eosin stain was used to visualize cell nuclei in spheroid
samples. The reagents used were as follows: Hematoxylin I (Richard-Allan, #7221,
Thermo Scientific, Waltham, Massachusetts), Clarifier I (Richard-Allan, #7401), Bluing
Reagent (Richard-Allan, #7301, Thermo Scientific, Waltham, Massachusetts), Eosin-Y
(Richard-Allan, #7111, Thermo Scientific, Waltham, Massachusetts ). The protocol for
this stain was prepared by Linda Jenkins, HT (ASCP). For spheroids, our lab has found
that 8 minutes was suitable for proper staining of nuclei and that 45 seconds was the time
required for proper staining of cytoplasmic materials. Exceeding these mentioned times
can lead to over-staining.
Masson’s Trichrome Stain
The Masson’s Trichrome stain was used to visualize ECM in spheroid samples
and performed according to the manufacturer’s protocol (Masson’s Trichrome Method
for Connective Tissue, Poly Scientific R&D Corporation). When using the Analine Blue
reagent, we report that 20 minutes (instead of the recommended 5 minutes) is the most
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suitable time for ECM visualization in spheroids. Slides containing spheroids were placed
onto trays and stains were applied using a transfer pipette, rather than dipping the slides
into reagents. This technique prevents spheroids from being washed off of the slides
during the staining process.

Tissue Sheet Viability
After three days of fusion, tissue sheets were fixed overnight using Z-Fix and
their viability was qualitatively studied using a LIVE/DEAD cell viability assay (Life
Technologies, CA, USA) with confocal microscopy. The staining was performed
according to the manufacturer’s protocol and imaged using a Nikon Eclipse Ti
microscope.

Immunohistochemistry for Functional Protein Markers
Immunofluorescence microscopy was used to qualitatively confirm SMC
phenotypic expression within tissue tube samples that had fused for 7 days. First, OCT
embedded histology sections (5 μm thick) were collected and cleared via two washes (5
min) in PBS and 1 wash in water. Samples were circled with a diamond tip pen.
Samples were treated with a 0.1% Triton X-100 to permeabilize samples (10 min). Slides
were washed 3x with water (5 min), followed by a 30 minute incubation with
Background Buster (Innovex Biosciences, CA, USA). Next, samples were washed 2x
water and 1x PBS. Once samples were prepped, they were incubated with primary
antibodies overnight at 4 °C in a humid chamber. Samples were washed 3x PBS,
followed by incubation with secondary antibodies for one hour at room temperature. As a
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control, samples were incubated with just the secondary antibody to ensure controlled
binding was occurring. Finally, samples were washed 3x PBS followed by incubation
with Hoechst 33342 to stain for nuclei (10 min, room temperature). Samples were
washed 3x PBS and cover slipped, and fluorescently imaged for Smooth Muscle Myosin
Heavy Chain (SMHC) and Smooth Muscle 22 (SM22) (FITC, Ex/Em 492/520), Smooth
Muscle Alpha Actin (SMAA) (Cy3, Ex/Em 552/570), and nuclei (Hoescht 33342, Ex/Em
343/483) using a Nikon Eclipse Ti microscope. SMHC, SM22 and SMAA are known
phenotypic markers of smooth muscle cells. Three tissue samples of were analyzed to
confirm that results were consistent.

Imaging
Stained spheroid sections were imaged using a Nikon (Tallahassee, Florida)
AZ100 multizoom microscope. Images were processed using NIS-Elements software
package from Nikon.

2.3 RESULTS
2.3.1 INDIVIDUAL JMCSS
The hematoxylin and eosin stains demonstrate the presence of nuclei in cellular
spheroids at Day 3 and Day 40 time points in spheroids with no iron oxide (Figure 2.2
A,B) and spheroids with iron oxide MNPs (Figure 2.2 C,D). The cells preferentially
align themselves over time to reduce configurational energy in both spheroid types, as is
expected [29, 35]. The Masson’s Trichrome stain demonstrates the presence of ECM in
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cellular spheroids at Day 3 and Day 40 time points in spheroids with no iron oxide
(Figure 2.3 A,B) and spheroids with iron oxide MNPs (Figure 2.3 C,D). The ECM
content increases in both spheroid types over time, as visualized by the increase in the
amount of blue stain throughout the spheroids.

2.3.2 TISSUES COMPOSED OF JMCSS
Histological examination of the tissue sheets and tubes shows that the manual
processing method yielded intact tissue structures with preserved morphology. Tissue
sheet sections were stained using an H&E stain and demonstrate the presence of cell
nuclei throughout the fused tissues after 3 days (Figure 2.4A). The Masson’s Trichrome
stain demonstrates the presence of collagenous ECM throughout the fused tissue (Figure
2.4B). A LIVE/DEAD stain of the fused tissue sheet qualitatively confirms the presence
of viable cells throughout the tissue, as seen by the large population of viable (green)
cells with only a small portion of dead (red) cells (Figure 2.4C). Tissue tube sections
were also stained using H&E stain and demonstrate the presence of cell nuclei throughout
the fused tissue after 7 days (Figure 2.5A). The Masson’s Trichrome stain demonstrates
that collagenous ECM is present throughout the tissue tube (Figure 2.5B). Tissue tubes
were fluorescently stained for known phenotypic smooth muscle cell markers: smooth
muscle myosin heavy chain (SMHC) (Figure 2.5C), smooth muscle 22 (SM22) (Figure
2.5D) and smooth muscle alpha actin (SMAA) (Figure 2.5E). Results demonstrate
positive expression of each of these key phenotypic markers in the tissue tubes (red for
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SMHC and SM22, green for SMAA), as well as the presence of nuclei throughout the
tissue using a Hoechst stain for nuclei (blue).

Hematoxylin and Eosin
Stain
Day 3
Day 40
a

b

c

d

NIO

JMCS

Figure 2.2. Hematoxylin and Eosin Stains of Cellular Spheroids Over Time. Cellular
spheroids were collected at Day 3 and Day 40 time points. Spheroids were fixed,
sectioned and then stained with hematoxylin and eosin. (a, b) Hematoxylin and eosin
stains of Day 3 and Day 40 cellular spheroids. (c, d) Hematoxylin and eosin stains of Day
3 and Day 40 Janus magnetic cellular spheroids. Here, the iron oxide magnetic
nanoparticles are black in the images. When compared to Day 3 spheroids, the Day 40
spheroids have preferentially aligned themselves in both spheroid types. (NIO = no iron
oxide, JMCS = Janus magnetic cellular spheroid). Magnification = 20x. Scale = 500 μm.
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Figure 2.3. Masson’s Trichrome Stains of Cellular Spheroids Over Time. Cellular
spheroids were collected at Day 3 and Day 40 time points. Spheroids were fixed,
sectioned and then stained using a Masson’s Trichrome staining kit. (a, b) Masson’s
Trichrome stains of Day 3 and Day 40 cellular spheroids. (c, d) Masson’s Trichrome
stains of Day 3 and Day 40 Janus magnetic cellular spheroids. Here, the iron oxide
magnetic nanoparticles are black in the images. The ECM content increases in both
spheroid types over time, as visualized by the increase in the amount of blue stain
throughout the spheroids (NIO = no iron oxide, JMCS = Janus magnetic cellular
spheroid). Magnification = 20x. Scale = 500 μm.
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Figure 2.4. Histological Examination of Tissue Sheets Composed of JMCSs. Tissue
sheets composed of magnetically patterned JMCSs were left to fuse for 3 days. After
three days, tissue sheets were fixed, processed, sectioned and then stained using an H&E
stain (Figure 2.4A), a Masson’s Trichrome stain (Figure 2.4B) and a LIVE/DEAD
viability stain (Figure 2.4C) (Scale Bars = 500 μm). The H&E stain demonstrates the
presence of cell nuclei throughout the fused tissue sheet. Nuclei are visualized as blue or
dark purple and cytoplasmic tissue elements are visualized as various shades of pink. The
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the
fused tissue sheet. Nuclei are visualized as dark red, collagen is visualized as blue, and
cytoplasmic tissue elements are visualized as various shades of red or pink. The iron
oxide magnetic nanoparticles are black in the images. The LIVE/DEAD stain
demonstrates that the tissue contains a large population of viable cells (green), with a
small population of dead cells (red) after 3 days of fusion.

Figure 2.5. Histological Examination of Tissue Tubes Composed of JMCSs. Tissue
tubes composed of fused JMCS tissue sheets were left to fuse for 7 days. After 7 days,
tissue tubes were fixed, processed, sectioned and then stained using an H&E stain
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(Figure 2.5A), Masson’s Trichrome stain (Figure 2.5B), or fluorescent IHC markers for
smooth muscle cell phenotype analysis (Figures 2.5C, 2.5D and 2.5E) (Scale Bars = 5
mm for Figures 2.5A and 2.5B; Scale Bars = 500 μm for Figures 2.5C, 2.5D and 2.5E).
The H&E stain demonstrates the presence of cell nuclei throughout the fused tissue tube,
as well as the gross structure of the tissue tube. Nuclei are visualized as blue or dark
purple and cytoplasmic tissue elements are visualized as various shades of pink. The
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the
fused tissue tube. The iron oxide magnetic nanoparticles are black in the images. Results
of staining tissue tube sections for smooth muscle cell phenotypic markers demonstrated
positive expression of SMHC (red) (Figure 3C), SM22 (red) (Figure 3D) and SMAA
(green) (Figure 3E). The presence of nuclei throughout the tissue was demonstrated using
a Hoechst stain for nuclei (blue).

2.4 DISCUSSION
Cellular spheroids are attractive for use as the building blocks for larger and more
complex tissues because they mimic the 3D native orientation of tissues and produce
their own ECM over time [11, 69]. The bottom up, scaffold free tissue engineering
approach with cellular spheroids is promising for the fabrication of larger tissues because
industrial systems are being developed to robotically scale tissue and organ fabrication
using automated spheroid bioprinters [69]. Spheroids with tissue specific functions
(hepatic, cardiac, bone, pancreatic, vascular) have been fabricated, which gives promise
to the developing technology [36, 70, 140-146]. Cellular spheroids are beginning to be
used in an industrial setting to fabricate micro-tissues for tissue fabrication and drug
screening, both of which are critical needs in the clinical setting [147]. High throughput
drug screening with cellular spheroids would drastically decrease testing time for safety
and efficacy and limit testing on animals.
To compare tissues fabricated in vitro from spheroids to native tissues, it is
critical to develop an automated method to rapidly process these tissues for histological
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examination of tissue structure, cellular orientation and ECM organization. Tissues
composed of spheroids are subject to poor mechanical properties, due to their fluidic
nature and lack of maturation [39]. Thus, care must be taken with these delicate samples
to preserve tissue integrity and tissue morphology during the processing steps.
In this work, a manual histological processing technique for spheroids and tissues
composed of spheroids was presented. This technique uses overnight fixation and also
overnight infiltration in paraffin. The chosen manual method of processing has been
compared to automatic processing with a SAKURA Tissue TEK VIP. When using the
automatic processor, spheroid samples have been lost and tissues composed of spheroids
have had their morphologies compromised. This is especially critical for tissue tubes
composed of spheroids, where it is important to maintain the morphology of the lumen
for further analysis of cells, markers, and ECM distribution. In general, tissue samples
composed of spheroids are delicate and the manual processing allows for proper care to
be taken. Manual processing allows for careful solution exchanges and prevents samples
from being lost because the sample can always been visualized. This research offers a
reliable method for preparing tissues to study the localization and viability of cells, the
organization of extracellular matrix and phenotypic expression of tissues composed of
cellular spheroids. This understanding is critical when developing tissue engineered
constructs that mimic native tissue. Though the method is sufficient for small scale
histological analyses, an automated histological processer must be developed in the future
to meet the need at the industrial scale. Morales and coworkers developed a method to
rapidly fix, process and embed tissue specimens in 1 hour by using a continuous flow of
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the working solutions [148]. Another strategy for making the process more highthroughput could be to embed multiple spheroid samples throughout the same paraffin
block, which reduces the amount of blocks to be made and sectioned [149].
Using the manual technique presented here, tissues of various shape, size and
composition were able to be processed and prepared for histological examination.
Sectioned specimens were stained using H&E, Masson’s Trichrome, LIVE/DEAD and
various IHC reagents. The H&E stain allowed for visualization of cell nuclei, the
Masson’s Trichrome stain highlighted collagen throughout the tissue, the LIVE/DEAD
stain demonstrated high cell viability in tissue sheets and IHC staining demonstrated
phenotypic expression expected of smooth muscle cells. These results qualify the
presented manual method of tissue processing for preparing tissues for standard stains,
like H&E, as well as specialized stains, like fluorescent IHC staining. The presented
method allowed for visualization of cells, characterization of collagen, localization of
iron oxide MNPs and analysis of phenotypic expression throughout tissues composed of
cellular spheroids. Having a full understanding of these tissue molecules and components
is critical for developing a tissue engineered construct that mimics native tissue.
Currently, conventional histological processors are not recommended to process spheroid
anatomic qualities and preserve morphological properties because of the risk for sample
dissipation and degradation. In the future, automated processors with fine meshed biopsy
bags, custom processing cassettes, EM tissue processing techniques and cryosection
techniques offer shorter potential turn-around times and will need to be developed, tested
and compared to the presented paraffin technique in the future.
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2.5 CONCLUSIONS
Given their widespread use in developmental biology, drug discovery and testing,
and tissue engineering, it is critical to further develop a method for preparing spheroids
and tissues composed of spheroids for histological examination in a rapid manner to
visualize and understand tissue structure, morphology and composition. Due to their
small size and delicate nature, spheroids cannot be fixed and dehydrated using
conventional histological automated tissue processors, and must be processed manually.
To accommodate numerous samples for high throughput histological analysis of
spheroids, an automated technique will be required to address the turn-around time and
eliminating possible user error. In the future, the development and optimization of stains
for spheroids and tissues composed of spheroids, like stains for localizing metallic
nanoparticles or markers for immunohistochemistry, will be required for developing a
better understanding of the tissues and their interactions with nanomaterials. This study
confirms that the method described here is suitable for processing and preparing
spheroids and tissues composed of spheroids for histological examination.
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CHAPTER 3
FUSION OF JANUS MAGNETIC CELLULAR SPHEROIDS
3.1 INTRODUCTION
A major challenge in tissue engineering is the in vitro fabrication of functional
tissue constructs with cell numbers, extracellular matrix (ECM) contents and mechanical
properties that mimic the native vasculature [36]. Scaffold-free cellular aggregates, or
spheroids, produce their own ECM, allow for precise control over cell number and can
fuse into complex tissue structures [11, 29, 34, 48]. Stimulation of ECM production and
tissue fusion is critical for the fabrication of complex tissue structures using spheroids
[34]. The formation of a network of ECM between and throughout adjacent spheroids is
critical for structural integrity and provides cues for the fusion process. Tissue fusion is a
self-assembly process in which two or more distinct cell populations, or tissues, make
contact and coalesce to form a single cohesive structure [11, 29, 34]. Factors mediating
tissue fusion include cell migration, cell-cell interactions, and cell-matrix interactions
[29, 30, 34] to minimize the overall system configurational energy, which results in
smaller tissue aggregates [12, 29]. Tissue contraction, which includes intracellular
cytoskeletal reorganization from cadherin-mediated adhesions, is thought to be
responsible for the conformational changes that cause fused tissues of complex
geometries to resolve into spheroids over time [50, 150].
Conventional tissue assembly and fabrication methods include cell printing, cell
sheet techniques, and patterned molds [11, 26, 29, 62]. These methods spatially orient the
cells and tissues into a desired position to create passive contacts, but do not promote
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active contact between cells and tissues to accelerate the tissue fusion process. Therefore,
the preparation of homogenous or cohesive engineered tissues remains a challenge when
using scaffold-free cellular aggregates. By incorporating magnetic nanoparticles (MNPs)
into cellular spheroids, these self-assembled tissues can be aligned and patterned using
magnetic force assembly [88, 90, 92, 93, 97, 151, 152]. Our lab developed the Janus
structure of magnetic cellular spheroids (JMCSs), which provides spatial control of iron
oxide MNPs to form two distinct domains: cells and extracellular MNPs [78]. Mattix and
coworkers reported that iron oxide MNPs do not adversely affect the viability of JMCSs
and that magnetic forces accelerated the fusion of JMCSs [78]. Unlike conventional
tissue patterning methods, magnetic fields are physical forces used to promote active cellcell contacts and interactions that arise from the adhesive and cohesive interactions
between cells under the influence of magnetic attraction [78].
Here, we report our results on manipulating spheroid composition and the effects
on JMCS fusion mediated by magnetic forces. The objective of this work was to
determine the mechanisms associated with the fusion of JMCSs. The hypothesis driving
this work is that spheroid composition, including cell content and ECM content, regulates
the fusion kinetics of JMCSs. Our results demonstrate the critical role of cell-cell and
cell-ECM interactions for mediating cellular spheroid fusion and show the potential use
of magnetic nanoparticles for stimulating ECM production in spheroids.
3.2 MATERIALS & METHODS
An overview of experimental procedures, parameters, and objectives can be found
in Table 3.1.
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Table 3.1. Experimental Plan for the Analysis of Collagen Production in Spheroids
and Factors Affecting the Fusion of JMCSs. Experiments were performed to analyze
the ability of cellular spheroids with and without MNPs to produce collagen over time.
Furthermore, studies were performed to determine what factors mediate JMCS fusion,
including cell number, collagen content and time. Cellular intermixing, which is a
hallmark of tissue fusion, was also analyzed in fusing spheroids. Finally, cell-cell and
cell-ECM interactions were studied to see the relative impact of each of fusing spheroids.
Multiple parameters were varied within each experiment as noted.

Cell Culture
Primary rat aortic smooth muscle cells were isolated from the aorta via careful
removal of the adventitia and endothelial cell lining, followed by a one hour incubation
with trypsin (0.25%) and collagenase (5 units/mL). Only passage numbers under ten were
used. All cells were cultured in monolayer cultures at 37 °C and 5% of CO 2 until
spheroid assembly. SMCs were cultured using Dulbeco’s Modified Eagle Medium:F-12
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(ATCC, 1:1, DMEM:F-12) supplemented with 10% fetal bovine serum (Atlanta
Biologics) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc.).

Spheroid Assembly

Spheroids (Janus Magnetic Cellular Spheroids and No Iron Oxide Spheroids)
were prepared using a method developed in our lab and previously described [76-78].
Equal volumes of solutions containing suspended iron oxide MNPs (Fe3O4, 20-30 nm,
SkySpring Nanomaterials, Inc.), collagen (Bovine, Type I, Life Technologies), and cells
in cell culture media were combined and dispensed as hanging drops (15 μL) to form
spheroids.

Collagen,

Type

I

was

prepared

according

to

the

manufacturer

recommendations and kept on ice prior to use for all samples. Collagen was only added at
the time of spheroid fabrication and not continuously added to the media. Formulations
calling for no collagen were replaced with an equal volume of media. Unless otherwise
noted, all spheroids were incorporated into studies after three days of incubation.

Controlling Collagen Content During Spheroid Fabrication
Collagen was only added to spheroids during the fabrication process and not
continuously supplemented in the media. To demonstrate that collagen content within
spheroids can be controlled during spheroid formation, histological examination with a
Masson’s Trichrome stain was used after 3 days of spheroid formation with varying
collagen contents (0.017 mg/mL, 0.1 mg/mL and 0.25 mg/mL).
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Viability
PrestoBlue cell viability assays were performed according to manufacturer’s
protocol (Life Technologies) in order to quantify cell viability, with at least 3 repeats per
sample. Spheroids were first dissociated via incubation with collagenase (5 units/mL)
(Collagenase Type IV), followed by incubation with trypsin (0.25%), and adherence
overnight on a well plate.

Spheroid Sizing
Spheroids with 5,000 cells per spheroid and 20,000 cells per spheroid were
fabricated and left to form for 3 days. After 3 days, spheroids were imaged using a Nikon
AZ100 microscope and their diameters measured using NIS Elements (Nikon) software
package.

Ring Fusion
Spheroid fusion was analyzed by tracking the fusion of spheroids into a ring. Ring
magnets were commercially purchased (2 mm OD, 1 mm ID, 1 mm thick, Super Magnet
Man) and attached to the bottom of a glass chamber slide. 25 individual spheroids of the
same formulation were carefully patterned around the ring pattern in a monolayer
formation. The low concentration (0.005 mg/mL) represents a minimal amount of
collagen added to spheroids. The high collagen concentration (0.3 mg/mL) represents the
most collagen that could be incorporated into the spheroids and still allow for placement
into a ring structure with a lumen. Magnets were removed after 48 hours and samples
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imaged using a Nikon AZ100 multizoom microscope. Four measurements for each ring
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each
time point. Samples were normalized with themselves, as each sample was analyzed as
the percent initial diameter. At least three repeats were performed for each sample.

Collagen Quantification
The collagen content in spheroids was determined using a hydroxyproline assay,
as previously described [153]. First, spheroids were hydrolyzed in 4N sodium hydroxide
at 120˚C for 2 hours. Samples were neutralized with 1.4N citric acid and pH balanced to
a range of 7.2 to 7.6. A hydroxyproline standard curve was prepared for calibration of
unknown samples. An aliquot of 200 µL was taken from each sample to be incubated
with a Chloramine T solution for 15 minutes and then a p-Dimethylaminobenzaldehyde
solution for 15 minutes at 65˚C. Next, experimental samples were prepared as triplicates
for optical number readings at 550 nm. Unknown samples were calculated based on the
hydroxyproline standard curve. Long term spheroid collagen content studies were
normalized to each respective group’s collagen content at Day 3.

Capillary Tube Fusion with Varying Collagen Content and Cell Numbers
Capillary tubes (500 µm diameter, CTechGlass, CT95-02) were used to study the
influence of collagen content and cell number on cellular spheroid fusion. JMCSs
composed of primary rat aortic smooth muscle cells were assembled and four of them
were placed into capillary tubes full of cell culture media. The first treatment was varying
collagen concentrations incorporated into spheroids, which were 0.017 mg/mL and 0.24
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mg/mL bovine collagen I (Life Technologies). The low concentration represents the
amount of collagen used for making rounded spheroids with some structural support. The
high collagen value represents the most collagen that could be incorporated into the
spheroids and still allow for placement in the capillary tubes without clogging. For the
varying collagen study, 20,000 cells per spheroid were used. The second treatment was
varying the cell numbers that were incorporated into spheroids, which were 5,000 cells
per spheroid and 20,000 cells per spheroid. For the varying cell number study, 0.017
mg/mL collagen concentration was used. Spheroid filled capillary tubes were placed
upright into 0.65 mL polypropylene conical tubes with cell culture media to allow
spheroids to settle to the bottom. Samples were exposed to magnetic forces by placement
on top of square magnets (K&J Magnetics, Inc., B881). Immediately after placement into
capillary tubes, the spheroids were imaged using an AMG EVOS fl Digital Inverted
Microscope to get initial diameter measurements of the spheroids using ImageJ. To
ensure that no gaps existed between the spheroids and complete contact existed, the
samples were exposed to magnetic forces prior to initial measurements. Spheroids were
left in capillary tubes for 24 and 48 hours prior to further imaging analysis. The 24 and 48
hour spheroid measurements were normalized to the initial measurements. At least three
repeats were used for each condition to confirm repeatability.

Cellular Intermixing
Rat aortic smooth muscle cell solutions were fluorescently labeled using a
Vybrant® CFDA SE Cell Tracer Kit (green) or PKH26 Red Fluorescent Cell Linker Kit
(red). Stains were performed according to manufacturer protocols (Life Technologies).
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The stained cell solutions were then used to fabricate JMCSs with varying collagen
concentrations (0.017 mg/mL and 0.24 mg/mL). The low concentration represents the
amount of collagen used for making rounded spheroids with some structural support. The
high collagen value represents the most collagen that could be incorporated into the
spheroids and still allow for placement in the capillary tubes without clogging.
Alternating in color, four spheroids were gently placed into capillary tubes (500 µm
diameter, CTechGlass, CT95-02). After 48 hours, fluorescent images were captured using
a Nikon Ti Eclipse microscope. The ratio view tool on NIS-Elements Software from
Nikon Instruments was used to visualize and compare cellular intermixing of the
fluorescently labeled spheroids. The ratio view function allows measurement of the ratio
of two wavelengths across multiple regions of interest and shows the ratio value by pixel.

Fusion Blocking
To understand the influences of various cell-cell and cell-matrix proteins on
spheroid fusion their functional capacity was inhibited. Four spheroids were gently
placed into capillary tubes (500 µm diameter, CTechGlass, CT95-02). Spheroid filled
capillary tubes were placed upright into a 0.65 mL polypropylene conical tube with cell
culture media to allow spheroids to settle to the bottom. Samples were exposed to
magnetic forces via placement of a square magnet below sample containers (K&J
Magnetics, Inc., B881). The media used in the capillary tubes and conical tube was
supplemented with the following in order to inhibit the function of cell-cell and cellmatrix interactions: monoclonal anti-N-cadherin antibody (clone GC-4, Sigma) (40
μg/mL), for inhibiting cell-cell interactions regulated by cadherins; and Anti-Mouse/Rat
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CD29 Functional Grade Purified (eBioscience) (5 μg/mL), for inhibiting the cell-matrix
interactions of integrin beta 1. After supplementation, spheroids were immediately
imaged using an AMG EVOS fl Digital Inverted Microscope and their diameters
measured using ImageJ. Fused tissue constructs were then imaged again at 48 hours and
their lengths measured. Samples were normalized with themselves over time and at least
five repeats were used for each treatment. The fusion of the treated samples was
compared to control samples without fusion blockers.

Histology
All samples were processed and sectioned via paraffin sectioning techniques
developed in our lab [137]. Spheroids were fixed, processed (5 µm sections), and stained
using either hemotoxylin and eosin (H&E) or Masson’s Trichrome stain.

Statistical Analysis
Statistical analyses were performed using an Analysis of Variance (ANOVA) test
to determine if differences were present amongst treatment groups. If differences were
determined from the ANOVA, a post hoc two tailed t-test was used to determine if
significant differences existed between treatment groups. Error bars on graphs represent
the standard deviation from the mean.
3.3 RESULTS
3.3.1 COLLAGEN PRODUCTION IN SPHEROIDS OVER TIME
The development of a viable tissue engineered construct with mechanical
properties similar to native tissues heavily relies on enhancing collagen production. An
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appealing aspect of cellular spheroids for tissue engineering applications is their ability to
dynamically produce their own ECM to meet required mechanical or functional needs of
the local environment [48]. Copper and iron ions have been shown to enhance collagen
crosslinking in tissues, modulate collagen gene expression and regulate intracellular
elastin production, which are critical for the organization and maturation of engineered
tissues [154-156]. Patients with beta-thalassaemia and other inherited hemolytic disorders
characterized with fluctuations in iron concentration demonstrate defective elastic fibers
[156]. Also, it has been shown that iron is associated with gene expression of encoding
ECM components [155]. Here, we tested the hypothesis that iron, a physiologically
essential nutritional element, could be associated with stimulating production of ECM
when iron oxide MNPs are integrated into cellular spheroids.
JMCSs and spheroids without MNPs were fabricated and incubated over 40 days
in cell culture media or cell culture media supplemented with ascorbic acid (50 µg/mL),
which is known to stimulate collagen production [26]. Initial collagen concentrations
were held constant at 0.017 mg/mL for spheroids with and without MNPs. Collagen
contents of different spheroid types were normalized to each group’s respective collagen
content at Day 3 to eliminate the contribution of the initial collagen added to spheroid
during the preparation. Results of hydroxyproline assays qualitatively demonstrate
increased collagen production in all spheroid types over time (p < 0.05, indicated by ‘+’)
(Figure 3.1). Results demonstrated that the addition of iron oxide MNPs in JMCSs
caused a significant increase in collagen production, when compared to their NIO
counterparts at Day 40 (p<0.05, as indicated by ‘_’). Further, the addition of ascorbic
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acid significantly increased ECM production of both spheroid types (p<0.05, as indicated
by ‘#’ for NIO and AANIO and ‘*’ for JMCS and AAJMCS groups). It should be noted
that the combination of Janus spheroids with ascorbic acid had a synergistic effect, as the
collagen content in these spheroids was significantly greater than in spheroids with
ascorbic acid supplementation and no MNPs (p<0.05, as indicated by ‘=’). Compared to
Day 3, at Day 40 NIO spheroids had 4.68 times more collagen content, ascorbic acid
treated NIO spheroids had 6.76 times more collagen content, JMCS spheroids had 6.32
times more collagen content and ascorbic acid treated JMCS spheroids had 8.21 times
more collagen content. Next, spheroids were histologically sectioned and stained with
hematoxylin and eosin and Masson’s Trichrome stains to visualize nuclei and collagen,
respectively, at Day 10, 20, 30 and 40 time points (Figure 3.1). It is expected that the
spheroids containing iron oxide magnetic nanoparticles will be larger in diameter, when
compared to spheroids without magnetic particles. To confirm that these two groups
contained similar collagen contents at the beginning of the study, a hydroxyproline assay
was used to quantify collagen at Day 3 for each group. Results showed that though the
spheroids differed in size, the collagen content is the same after incorporation of the
collagen and MNPs during spheroid formation (Figure 3.2). Histological examination
suggests that JMSCs and MNP-free spheroids secrete their own collagen, as visually
confirmed by an increase in collagen within cellular spheroids over time. As expected,
supplementation with ascorbic acid increased collagen production over time in tissue
sections. When sectioning spheroids, it is difficult to obtain sections at the same depth in
different spheroid populations, which led to the variability in size for tissue sections.
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Overall, these results demonstrate that iron oxide MNPs stimulate and enhance collagen
synthesis when compared to MNP-free controls.

Figure 3.1. Effect of Iron Oxide MNPs on Collagen Synthesis within JMCSs. Results
of hydroxyproline assays qualitatively demonstrate increased collagen production in NIO,
AANIO, JMCS and AAJMCS spheroids over 40 days (p<0.05, as indicated by +).
Results demonstrated that the addition of iron oxide MNPs in JMCSs caused a significant
increase in collagen production, when compared to their NIO counterparts (p<0.05, as
indicated by ‘_’). Further, the addition of ascorbic acid significantly increased ECM
production of both spheroid types (p<0.05, as indicated by ‘#’ for NIO and AANIO and
‘*’ for JMCS and AAJMCS groups). It should be noted that the combination of Janus
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spheroids with ascorbic acid had a synergistic effect, as the collagen content in these
spheroids was significantly greater than in spheroids with ascorbic acid supplementation
and no MNPs (p<0.05, as indicated by ‘=’). Results of the Masson’s Trichrome stain
suggest that all spheroid samples secrete their own collagen over time (increase in blue),
which indicates that MNPs have no adverse effects on collagen synthesis within cellular
spheroids. NIO= No Iron Oxide, AANIO=Ascorbic Acid No Iron Oxide, JIO=Janus Iron
Oxide, AAJIO=Ascorbic Acid Janus Iron Oxide.

Figure 3.2. Collagen Content in Day 3 Spheroids With and Without MNPs. After
three days, no iron oxide spheroids and JMCSs were collected and their collagen contents
analyzed using a hydroxyproline assay. Results demonstrate that there is no difference
between the collagen contents in spheroids with and without magnetic nanoparticles
(p>0.05) after three days.

The cell number of a tissue engineered construct is critical for functionality [11,
29, 157]. Here, JMCSs with 5,000 cells per spheroid and 20,000 cells per spheroid were
fabricated and incubated in cell culture media over 40 days. Initial collagen
concentrations were held constant at 0.017 mg/mL for spheroids with and without MNPs.
Collagen contents of different spheroid types were normalized to each group’s respective
collagen content at Day 3. Qualitative results showed that both spheroid types produced
collagen over time (p < 0.05, as indicated by ‘+’) (Figure 3.3). These results indicate that
85

lower cell number spheroids produce similar amounts of collagen, relative to high cell
number samples, as there were not significant differences between samples at Day 20,
Day 30 and Day 40 time points (p > 0.05). The results show that lower cell number
spheroids produce more collagen, relative high cell number samples, as there was
significant differences between samples at Day 10 (p<0.05, as indicated by ‘*’). This
suggests that the differences in cell number may not be significant after the spheroids are
incubated for 10 days or more, which would lead to similar collagen production between
the two groups. Spheroids were histologically sectioned and stained with hematoxylin
and eosin and Masson’s Trichrome stains to visualize nuclei and collagen, respectively, at
Day 10, 20, 30 and 40 time points (Figure 3.3). It is expected that the size of the spheroid
will be different among 5,000 and 20,000 cell per spheroid samples. Spheroids with each
cell density were collected after three days of formation, imaged and their diameters
measured. Results show that 20,000 cell per spheroid samples were significantly larger
than the 5,000 cell per spheroid counterparts (Figure 3.4), which was anticipated due to
the presence of more cells. A histological examination demonstrated that both cell
densities had cell nuclei through the spheroid and that each saw an increase in collagen
production over time, as seen by the increase in blue staining throughout the samples
from the Masson’s Trichrome stain. Again, the variability in the size of the spheroid
sections can be attributed to difficulty in sectioning spheroids at the same depth amongst
different spheroid groups.
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Figure 3.3. Effect of Cell Number on Collagen Synthesis within JMCSs. Results of
hydroxyproline assays qualitatively demonstrated increased collagen production in
spheroids with both, 5,000 and 20,000 cell per spheroid samples over 40 days (p<0.05, as
indicated by ‘+’). The results indicate that lower cell number spheroids produce similar
amounts of collagen, relative to high cell number samples, as there were not significant
differences between samples at Day 20, Day 30 and Day 40 time points (p > 0.05). The
results show that lower cell number spheroids produce more collagen, relative high cell
number samples, as there was significant differences between samples at Day 10 (p<0.05,
as indicated by ‘*’). This suggests that the differences in cell number may not be
significant after the spheroids are incubated for 10 days or more, which would lead to
similar collagen production between the two groups. Results of the Masson’s Trichrome
stains suggest that all spheroid samples produce their own collagen over time (increase in
blue stain), which indicates that cell number has no adverse effects on collagen synthesis
within cellular spheroids.
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Figure 3.4. Spheroid Diameter with Varying Cell Numbers at Day 3. After three
days, spheroids composed of 5,000 and 20,000 cells per spheroid were imaged and their
diameters measured. Results demonstrate that the 20,000 cells per spheroid samples have
diameters that are significantly larger than the 5,000 cells per spheroid samples after three
days of formation (p<0.05, as indicated by ‘*’). These results were anticipated due to the
presence of more cells in the 20,000 cells per spheroid samples.
3.3.2 FACTORS AFFECTING SPHEROID FUSION
To drive the fusion process for the self-assembly of complex tissues, tissue
spheroid building blocks must be in direct contact [11]. Morgan’s lab reported modeling
fusion kinetics of tissue toroids over time, which were fabricated from cell solutions [50,
52]. Here, the roles of cell number and ECM content were evaluated for their potential to
influence the fusion of cellular spheroids into a tissue ring. Twenty five JMCSs were
patterned on ring magnets and left to fuse for 48 hours prior to removal of the magnetic
forces. After removal of the magnetic template, two phenomena occur: fusion and
contraction. The individual spheroids in the tissue rings will continue to fuse together,
while the ring tissue as a whole will contract, or resolve to a rounded spheroid, due to
forces generated through cell-cell adhesions and actin networks [50, 150, 158]. Images of
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assembled tissue rings were taken daily and the contraction was quantitatively tracked.
Complete fusion and contraction was defined as a lack of a lumen within the tissue ring.
First, the influence of cell number was analyzed with samples both with and
without ECM. In the presence of ECM (0.017 mg/mL collagen added during fabricaiton),
results indicated that lower cell numbers, 5,000 cells per spheroid tested here, showed the
fastest and most complete fusion and contraction over 156 hours when compared to
higher cell numbers, 20,000 cells per spheroid tested here (84 hr, 108 hr, 132 hr and 156
hr; p < 0.05, as indicated by ‘*’) (Figure 3.5a). Visual analysis confirmed that low cell
number rings corresponded to the most complete and accelerated fusion and contraction
compared to their higher cell number counterparts (Figure 3.5b).
Next, the effect of ECM content on ring fusion and contraction was studied by
varying the collagen content added to cellular spheroids during fabrication, while holding
the cell number constant (20,000 cells per spheroid). To demonstrate that collagen
content within spheroids can be controlled during spheroid formation, histological
examination with a Masson’s Trichrome stain was used after 3 days of spheroid
formation with varying collagen contents added. Results of the stain showed an increase
in royal blue color throughout the spheroid as the amount of collagen added during
spheroid formation was increased from 0.017 mg/mL to 0.1 mg/mL to 0.25 mg/mL
(Figure 3.6a). Presto blue viability assays confirmed that the addition of collagen content
had no adverse effect on spheroid viability at 1 week in rat aortic smooth muscle cells
and fibroblasts, when compared to spheroids without collagen added during spheroids
formation (Figure 3.6b). Results of ring studies showed that lower collagen contents
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(0.005 mg/mL) demonstrated the fastest and most complete fusion and contraction when
compared to higher collagen spheroids over time (0.3 mg/mL) (84 hr, 108 hr and 132 hr;
p < 0.05, as indicated by ‘*’) (Figure 3.7a). Visual analysis highlighted the differences in
fusion and contraction characteristics based on collagen content (Figure 3.7b).

Figure 3.5 Effects of ECM on Ring Fusion and Compaction. The effects of varying
collagen contents for tissue fusion and compaction was quantified over time for rings
composed of JMCSs with two collagen contents, 0.005 mg/mL and 0.3 mg/mL. (a) At the
84 hr, 108 hr, and 132 hr timepoints the percent initial ring diameters of the 0.005 mg/mL
collagen spheroids were significantly smaller when compared to the 0.3 mg/mL collagen
spheroid counterparts (p<0.05, as indicated by ‘*’). Four measurements for each ring
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each time
point. (b) Visual analysis of ring fusion confirms that collagen content plays a significant
role in tissue fusion and compaction, with decreases in fusion and compaction becoming
evident with increasing collagen concentrations.
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Figure 3.6. Controlling Collagen Content During Spheroid Formation. (a) In order to
demonstrate that collagen content could be controlled during spheroid formation,
spheroids were fabricated with a range of collagen concentrations and then histologically
examined using a Masson’s Trichrome stain after three days of formation. Spheroid
sections with 0.017 mg/mL, 0.1 mg/mL and 0.25 mg/mL collagen concentrations were
stained and results show that as the collagen concentration within the spheroid was
increased during spheroid fabrication, an increase in blue color was seen in spheroid
sections. This demonstrates that collagen content can be controlled during the formation
of spheroids. (b) To ensure that a range of collagen contents can be safely incorporated
into spheroids without adverse effects on cell viability, Presto Blue cell viability assays
were performed. Spheroids were formed with collagen concentrations that ranged from
0.01 mg/mL to 1.3 mg/mL. When compared to spheroids without any added collagen,
results showed that the addition of the collagen during spheroid formation had no adverse
effects on cell viability through one week.
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Figure 3.7. Effects of ECM on Ring Fusion and Compaction. The effects of varying
collagen contents for tissue fusion and compaction was quantified over time for rings
composed of JMCSs with two collagen contents, 0.005 mg/mL and 0.3 mg/mL. (a) At the
84 hr, 108 hr, and 132 hr timepoints the percent initial ring diameters of the 0.005 mg/mL
collagen spheroids were significantly smaller when compared to the 0.3 mg/mL collagen
spheroid counterparts (p<0.05, as indicated by ‘*’). Four measurements for each ring
diameter were recorded (vertical, horizontal and two diagonals) and averaged at each
time point. (b) Visual analysis of ring fusion confirms that collagen content plays a
significant role in tissue fusion and compaction, with decreases in fusion and compaction
becoming evident with increasing collagen concentrations.
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To study the influence of collagen on spheroid fusion, 0.017 mg/mL and 0.24
mg/mL collagen concentrations were used with 20,000 cells per spheroid and 0.3 mg/mL
iron oxide. To study the influence of cell number on spheroid fusion, 5,000 and 20,000
cells per spheroid were used with 0.017 mg/mL collagen and 0.3 mg/mL iron oxide.
Spheroid filled capillary tubes were exposed to magnetic forces via placement of a square
magnet below sample containers. Results demonstrate that low collagen JMCSs (0.017
mg/mL) fused into a more cohesive tissue at 24 and 48 hour time points, as the tissue
construct sizes were 71% and 65% of initial tissue sizes, respectively (Figure 3.8a). High
collagen spheroids (0.3 mg/mL) experienced minimal fusion, as the tissue construct sizes
were 93% and 97% of initial tissue sizes are 24 and 48 hour time points, respectively.
Upon examining the images for low and high collagen groups, the low collagen group
tissue construct size was statistically significantly lower at both time points when
compared to the high collagen group (p < 0.05, as indicated by ‘*’).
Results demonstrate that low cell number spheroids had fused into constructs that
were 81% and 68% of initial sizes at 24 and 48 hour time points, respectively (Figure
3.8b). High cell number spheroids had fused into constructs that were 66% and 59% of
initial sizes at 24 and 48 hour time points, respectively, which was statistically
significantly lower than the 5,000 cells per spheroid group at the 24 hour time point (p <
0.05, as indicated by ‘*’). These results suggest that low collagen content allows for more
cell to cell interactions and cell contraction, and ultimately faster and more complete
fusion. With an increase in collagen content, cells become enmeshed in the dense
collagen network and their mobility is limited. This prevents the formation of cell-cell
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Figure 3.8. Tissue Fusion in JMCSs with Varying Collagen Content and Varying Cell
Number Mediated by Magnetic Forces. JMCSs were assembled and placed into capillary tubes
full of cell culture media. Samples were exposed to magnetic forces via placement of a square
magnet below sample containers. (a) Results demonstrate that low collagen JMCSs (0.017 mg/mL)
fused into a more cohesive tissue at 24 and 48 hour time points, as the tissue construct sizes were
71% and 65% of initial tissue sizes, respectively. High collagen spheroids (0.3 mg/mL) experienced
minimal fusion, as the tissue construct sizes were 93% and 97% of initial tissue sizes are 24 and 48
hour time points, respectively. At both timepoints, the tissue construct sizes of the low collagen
JMCSs were significantly smaller than the high collagen JMCSs (p<0.05, as indicated by ‘*’).
Visual analysis shows that low collagen spheroids fused into a more homogenous structure after 48
hours, while the high collagen spheroids fused minimally and the individual spheroids can still be
seen. (b) Results demonstrate that low cell number spheroids (5,000 cells per spheroid) had fused
into constructs that were 81% and 68% of initial sizes at 24 and 48 hour time points, respectively.
High cell number spheroids (20,000 cells per spheroid) had fused into constructs that were 66% and
59% of initial sizes at 24 and 48 hour time points, respectively, which was statistically significantly
lower than the 5,000 cells per spheroid group at the 24 hour time point (p < 0.05, as indicated by
‘*’). Visual analysis shows that both cell types fuse to similar sized constructs after 48 hours.
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adhesions, which are critical to the fusion process. As the cell number increases and
collagen content remains constant, there are more opportunities for cell to cell
interactions and contacts, which is conducive to promoting faster and more complete
fusion in a smaller amount of time. Spheroids with lower cell numbers provide an
environment that allows for cells to be mobile and make new cell-cell adhesions, but
there are not as many of these contacts due to the lower cell number and this could delay
the fusion of tissues.

3.3.3 CELLULAR INTERMIXING
A hallmark of tissue fusion is cellular intermixing to create a homogenous tissue
[150]. Here, we measured the influence of collagen content and cell number on cellular
intermixing during spheroid fusion in capillary tubes. Spheroids with varying collagen
content and cell number were fluorescently labeled and allowed to fuse for 48 hours in
capillary tubes with magnetic forces prior to imaging. Results demonstrated that high
collagen (0.24 mg/mL) spheroids experienced minimal cellular intermixing (8.6%), as
demonstrated by the lack of intermixing of fluorescent signal using the ratio view tool in
NIS-Elements software (Figure 3.9). Low collagen (0.017 mg/mL) spheroids exhibited
significantly more cellular intermixing (22.1%) between adjacent spheroids, as
demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by ‘*’). These
results indicate that collagen content influences cellular intermixing and cell migration,
which is critical for the fusion process. While collagen content may provide the structural
support required for developing tissues, these results indicate that collagen can slow
cellular intermixing and migration, both of which are critical to tissue fusion.
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Results from studying the influence of varying cell number on spheroid cellular
intermixing demonstrated that low cell number spheroids experienced minimal cellular
intermixing (10.1%), as demonstrated by the lack of intermixing of fluorescent signal
using the ratio view tool in NIS-Elements software (Figure 3.10). High cell number
spheroids had significantly more cellular intermixing (22.1%) between adjacent
spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by
‘*”). These results indicate that cell number influences cellular intermixing and cell
migration, which are both important during the fusion process.

Figure 3.9. Cellular Intermixing in JMCSs with Varying Collagen Content.
Spheroids with varying collagen content and cell number were fluorescently labeled and
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allowed to fuse for 48 hours in capillary tubes with magnetic forces prior to imaging. (a)
Results demonstrated that high collagen (0.24 mg/mL) spheroids experienced minimal
cellular intermixing (8.6%), as demonstrated by the lack of intermixing of fluorescent
signal using the ratio view tool in NIS-Elements software. Low collagen (0.017 mg/mL)
spheroids had more significantly more cellular intermixing (22.1%) between adjacent
spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05, as indicated by
‘*’).

Figure 3.10. Cellular Intermixing in JMCSs with Varying Cell Number. Results from
studying the influence of varying cell number on spheroid cellular intermixing
demonstrated that low cell number (5,000 cells per spheroid) spheroids experienced
minimal cellular intermixing (10.1%), as demonstrated by the lack of intermixing of
fluorescent signal using the ratio view tool in NIS-Elements software. High cell number
spheroids (20,000 cells per spheroid) had significantly more cellular intermixing (22.1%)
between adjacent spheroids, as demonstrated by the mixing of fluorescent signal (p<0.05,
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as indicated by ‘*’). These results indicate that cell number influences cellular
intermixing and cell migration, which are both important during the fusion process.

3.3.4 CELL-CELL AND CELL-ECM INTERACTIONS
The biological relevance of self-assembly of spheroids [159] and even the forces
driving the self-assembly of tissue [51] have been reported. However, there is a gap in the
literature regarding the influence of cell-cell and cell-matrix proteins on tissue fusion.
Work by Lin and coworkers describes studying the effect of cadherins and integrins
during spheroid formation using hepatoma spheroids, yet not much is known about the
role of integrins and cadherins during spheroid fusion [160]. To study cell-cell
interactions in fusing spheroids, we tested the inhibition of cadherins, which are a family
of glycoproteins involved in calcium dependent cell adhesion. Studies have shown that
inhibition with anti-cadherin antibodies induced dissociation of two dimensional cell
layers [161]. Integrins are major adhesion receptors and span across the cell membrane.
They are responsible for regulating cell to ECM binding and making transmembrane
connections to the cytoskeleton to activate intracellular signaling pathways. The
concentrations of cadherin and integrin blockers were 40 μg/mL and 5 μg/mL,
respectively, which are comparable to work using blockers in studies with forming
spheroids by Lin and toroids by Morgan [51, 160]. Results demonstrated that spheroids
with functional inhibition of cadherins exhibited tissue construct sizes that were 81% of
the initial sizes after 48 hours (Figure 3.11). For cell-ECM interactions, results showed
that spheroids with functional inhibition of integrins exhibited tissue construct sizes that
were 85% of the initial sizes after 48 hours (Figure 3.11). Control spheroids without
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fusion inhibition had tissue construct sizes that were 68% of the initial, and these results
were statistically significantly smaller (p < 0.05, as indicated by ‘*’) than both the anticadherin and anti-integrin spheroids, which demonstrates that cell-cell and cell-matrix
proteins do play a role in tissue fusion. However, significant differences were not
observed between the influences of cadherins and integrins, which suggests that both
cell-cell and cell-matrix interactions are involved in fusion and that other cell-cell and
cell-matrix protein blockers still need to be tested. These results add to the understanding
of the complex mechanisms behind tissue fusion and show the potential for future tissue
fabrication experiments to be tailored using optimal spheroid formulations for rapid and
complete tissue fusion.

Figure 3.11. Influence of Cell-ECM and Cell-Cell Interactions on Spheroid Fusion.
For studying cell-matrix interactions, the function of integrins was inhibited with an antiintegrin functional grade antibody in fusing spheroids in capillary tubes. Results showed
that spheroids with functional inhibition of integrins had tissue construct sizes that were
85% of the initial sizes after 48 hours. Results demonstrated that spheroids with
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functional inhibition of cadherins had tissue construct sizes that were 81% of the initial
sizes after 48 hours. Control spheroids without fusion inhibition had tissue construct sizes
that were 68% of the initial, and these results were statistically significantly smaller than
anti-integrin and anti-cadherin spheroids (p<0.05, as indicated by ‘*’), which
demonstrates that cell-matrix and cell-cell proteins do play a role in tissue fusion.

3.4 DISCUSSION
In this work, we have demonstrated that iron oxide MNPs stimulate the synthesis
of collagen in cellular spheroids, when compared to no iron oxide control spheroids. This
stimulation is perhaps due to the interactions of cells on the surface of the nanoparticles
or release of iron ions during degradation in spheroid (20). Further, our results show that
the influences of iron oxide on collagen synthesis are similar to that of ascorbic acid, a
known collagen synthesis stimulant. Future work will include studying the influence of
MNPs on collagen crosslinking and accelerating the maturation of tissues assembled with
JMCSs.
Bottom up engineering approaches, like cell sheet and cellular spheroid
techniques, allow for control over the cell number and ECM content. However, the role
of cell-cell and cell-ECM interactions on tissue fusion has not been fully understood. Our
results demonstrate that the composition of the building block for tissue fabrication is
critical because cell number and ECM content mediate the fusion process. The active
fusion created from the physical magnetic forces increased cell-cell adhesions, which is
perhaps mediated by increased cadherin interactions. This activity may lead to
downstream intercellular and intracellular signaling that promotes fusion through cell
migration and reorganization, ECM remodeling and cytoskeletal contraction. Future
research must involve not only accelerating the fusion of tissues, but also studying the
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deposition of other ECM proteins, like elastin and fibronectin, and the enhancement of
mechanical properties.
Overall, our results show that it is not only the magnetic forces, but the
composition of the spheroids used that is important to accelerate fusion of spheroids
when they are exposed to magnetic forces. Results from tissue ring and capillary studies
show that ECM content plays a role in mediating tissue fusion, as higher collagen content
decreases the rate of tissue fusion. While high collagen content spheroids may not
provide for the most cell intermixing, as seen in Figure 7, it is critical for providing
structural integrity of our tissue at later time points and when building larger tissues as
shown in Figure 4 using rings. In previous work from our lab, fluorescently labeled high
collagen tissue tubes that were fused for 24 hours showed minimal cell intermixing, as
demonstrated by maintained spatial orientation of endothelial cell, smooth muscle cell
and fibroblast layers. Our work presented here confirms that minimal cell intermixing is
occurring at early timepoints between adjacent spheroids in capillary tubes. DvirGinzberg and coworkers showed that the cell number is critical to fabricating liver tissue
constructs, as higher cell number spheroids led to increased viability and metabolic
output, compared to lower cell numbers [157]. This indicates that using a physiologically
relevant cell number is not only critical to tissue formation, but also in defining tissue
functionality. Future work will include monitoring the cell number in individual
spheroids and fusing spheroids over time, to understand how cell number influences the
developing tissues. Our work has shown that the fusion process is regulated by cell-cell
and cell-matrix interactions, as inhibition of cadherins and integrins led to less fusion
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over time, when compared to untreated controls. Our work represents the begining in
understanding how spheroid composition is critical for the fusion of spheroids into
complex tissues mediated by magnetic forces. Using this information, more effective and
applicable engineered tissues may be developed due to optimized predictions prior to
assembly.

3.5 CONCLUSIONS
In conclusion, spheroid composition is critical to the fusion process and
manipulation of the composition was utilized to study fusion kinetics of JMCSs mediated
by magnetic forces. Results showed that ECM content and cell number play a key role in
mediating the fusion of cellular spheroids into complex tissues. Results showed that iron
oxide MNPs in JMCSs stimulate collagen production, which is critical for scaffold free
tissue engineering. Further, results demonstrated that cell-cell and cell-ECM interactions
in spheroids are critical in determining the fusion dynamics of tissues. This new
understanding of JMCS composition and its influence on fusion can be applied to the
fabrication of larger tissues, like blood vessels. This could be a change in paradigm when
related to tissue engineering approaches because more collagen does not result in
enhanced fusion. Future work will involve using magnetic forces to induce maturation of
assembled tissue constructs, with a focus on enhancing ECM production and mechanical
properties.
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CHAPTER 4
MATURATION OF TISSUES COMPOSED OF JANUS MAGNETIC CELLULAR SPHEROIDS
4.1 INTRODUCTION
The three steps in bioprocessing of tissues using cellular spheroids are preprocessing, processing and post-processing. The preparation of the spheroids to be used
as the building blocks for tissue fabrication is known as pre-processing. The patterning of
the cellular spheroids into the desired orientation and fusion of adjacent spheroids is
known as processing. Tissue fusion is a process in which two or more distinct cell
populations, or tissues, make contact and form a single cohesive structure over time [11,
29, 34]. The post-processing step uses bioprocessing techniques, like mechanical
stimulation, to mature the tissues over time. The goal of tissue maturation is to improve
the mechanical properties, ECM contents and functionality of the developing tissues.
Fabricating tissue that has suitable mechanical properties can take months, or more than a
year, due to cell culturing time and long periods of post processing [26, 57].The
underlying mechanisms of the processing and post-processing steps, which are critical to
the development of tissue engineered constructs, are not yet clearly understood.
Understanding and accelerating both, tissue fusion and maturation, is critical for
producing tissue engineered construct on demand.
For vascular tissue applications, cyclic radial strain has been shown to enhance
the strength of tissue engineered vascular mediums by 22-57% and increase collagen
content by 22%, when compared to statically cultured controls [56, 83]. However, the
parameters for optimal maturation (frequency, magnitude, time of stimulation) have not
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been defined [56, 57, 82, 83, 85]. These studies overlook another force experienced by
blood vessels, longitudinal stretch. Almost all arteries in vivo experience longitudinal
strain (axial), with magnitudes ranging from 40% to 65% [162-166]. Local tissue growth
or atrophy during development, weight gain/loss, pregnancy, parturition, sustained
exercise programs, and pathological conditions will alter longitudinal forces experienced
in vivo [162-164]. A study by Gauvin and coworkers suggests that tissue sheets
composed of human dermal fibroblasts exposed to static and dynamic longitudinal strain
experienced increased expression of type I collagen and elastin in western blot analysis
when compared to static controls [81]. Additionally, the axial ultimate tensile strength
increased by 1.856 fold when compared to statically cultured tissues and the axial
modulus increased by 1.724 fold when compared the statically cultured tissues. Further,
this same study showed that tissues exposed to static and dynamic longitudinal strain
experienced preferential cellular and ECM alignment parallel to the axis of the forces
applied. Han and coworkers studied the effect of longitudinal stretch on vascular function
and wall remodeling using porcine carotid arteries [166]. Vessels were stretched 20%
more than in vivo for five days in a bioreactor system under pulsatile flow at
physiological pressure. For both, stretched and control vessels, results demonstrated high
viability using an MTT assay and ethidium-positive cell counting. Both groups
demonstrated significant contractile response to norepinephrine (10% diameter
contraction) [166]. The results of a BrdU proliferation assay indicated that longitudinal
stretching promotes cell proliferation, while maintaining arterial function [166].
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Scaffold-free cellular aggregates, or tissue spheroids, mimic the 3D orientation of
native tissue and produce their own extracellular matrix over time, making them
attractive for tissue fabrication [11, 29, 34, 48]. Magnetic nanoparticles (MNPs) have
been incorporated into cellular spheroids for alignment and patterning of tissues mediated
by magnetic forces [36, 76-78, 88, 90, 92, 93, 97, 122, 151, 152], but the use of magnetic
forces for accelerating maturation of vascular constructs has not been studied. Previously,
magnetic forces have been used to mature bone constructs, demonstrating the potential of
inducing desired differentiation and increased ECM production within 1 to 3 week
treatment times [130, 131]. The rationale is that magnetically induced mechanical
stimulation of the MNP containing tissues should cause preferential alignment of cells
and deposition of ECM in response to the applied magnetic forces. Magnetic force
technologies are attractive for tissue engineering applications because they allow for
precise and controlled manipulation of the tissues at a distance with magnetic fields [36,
76-78, 91, 113, 122, 125, 167].
In this work, we present the use of magnetic forces for mechanical maturation of
tissues composed of Janus Magnetic Cellular Spheroids (JMCSs) for vascular tissue
applications. The Janus method of spheroid fabrication allows for the creation of
separation between cells and extracellular MNPs, while maintaining cell viability,
functionality and phenotypic expression over time [37, 76-78, 122]. The objective of this
work is to investigate the effects of magnetic forces on tissues composed of JMCSs with
respect to ECM deposition and mechanical properties over time. The hypothesis driving
this research is that magnetic forces can mechanically stimulate tissues composed of
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JMCSs to stretch the tissues in a controlled, cyclic uniaxial longitudinal direction to
induce maturation over time. The rationale is that if magnetic forces can mediate the
maturation of the tissue engineered construct composed of JMCSs, then the mechanical
properties and ECM deposition within the developing tissue can be improved over time
when compared to statically cultured tissues. To our knowledge, we are the first group to
test cyclic longitudinal stretching mediated by magnetic forces to accelerate the
maturation of tissues composed of JMCSs. Understanding how magnetic forces facilitate
the maturation of tissues composed of JMCSs over time could provide the foundation for
fabricating tissues tailored to specific applications.
4.2 MATERIALS & METHODS
An overview of experimental procedures, parameters, and objectives can be found
in Table 4.1.
Table 4.1. Experimental Plan for Maturation of Tissues Composed of JMCSs
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Cell Culture
For this work, primary rat aortic smooth muscle cells (SMCs) were isolated from
the aorta via careful removal of the adventitia and endothelial cell lining, followed by a
one hour incubation with trypsin (0.25%) and collagenase (5 units/mL). Passage numbers
under ten were used. SMCs were cultured in monolayers at 37 °C and 5% of CO2 until
spheroid assembly. SMCs were cultured using Dulbeco’s Modified Eagle Medium:F-12
(ATCC, 1:1, DMEM:F-12) supplemented with 10% fetal bovine serum (Atlanta
Biologics) and 1% penicillin-streptomycin-amphotericin (MediaTech, Inc.).

Spheroid Formation
Spheroids were prepared using a method previously described and developed in
our lab [76-78]. Our lab has developed a Janus structure of magnetic cellular spheroids
(JMCS) and this provides spatial control of magnetic nanoparticles (MNPs) to create two
discrete domains: extracellular MNPs and cells[78]. Uniform volumes of solutions
comprised of suspended iron oxide MNPs (Fe3O4, 20-30 nm, SkySpring Nanomaterials,
Inc., Texas, USA), collagen (Bovine, Type I, Life Technologies, California, USA), and
cells in cell culture media were mixed and dispersed onto petri dishes using the hanging
drop technique into 15 μL droplets. For these studies, spheroids were fabricated with
20,000 cells each. Primary rat aortic smooth muscle cells were used for the tissue samples
presented in this work. Spheroids were left to form for three days prior to use. Collagen
was prepared according to the recommendations of the manufacturer and kept on ice
before use in all samples. For long term studies, spheroids were placed into non-tissue
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culture treated 96 well plates in the presence of cell culture media, with or without
ascorbic acid supplementation (50 μg/mL).

Tissue Sheet Fabrication
Monolayer sheets composed of JMCSs were assembled using a strip of magnets
(2.5 mm outer diameter, 5 mm length, K&J Magnetics, Inc., Pennsylvania, USA). Five
magnets were attached to the underside of a 6 well plate (Greiner Bio-One, North
Carolina, USA) and a glass cover slip (micro cover glass 22x30 mm, VWR,
Pennsylvania, USA) was positioned directly over the magnets within the well plate to
prevent spheroid adherence to the well plate. The wells were filled with cell culture
media and 1,000 JMCSs of the same formulation were carefully aligned on the coverslip
using a pipette tip and incubated at 37°C and 5% CO2 for 3 days to allow fusion to occur.

Collagen Quantification
The collagen content in the media that was produced by the tissue sheets was
determined using a hydroxyproline assay, as previously described [153]. First, the media
was collected, frozen and then lyophilized. Samples were hydrolyzed in 4N sodium
hydroxide at 120˚C for 2 hours. Samples were neutralized with 1.4N citric acid and pH
balanced to a range of 7.2 to 7.6. A hydroxyproline standard curve was prepared for
calibration of unknown samples. An aliquot of 200 µL was taken from each sample to be
incubated with a Chloramine T solution for 15 minutes and then a pDimethylaminobenzaldehyde solution for 15 minutes at 65˚C. Next, experimental
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samples were prepared as triplicates for optical number readings at 550 nm. Unknown
samples were calculated based on the hydroxyproline standard curve. Day 3 and 7
samples were normalized to each respective group’s collagen content at Day 1.

Maturation with Magnetic Forces
After ten days of fusion, the magnetic templates underneath the well plates
containing the fused magnetic cellular sheets were removed. The wells containing the
fused magnetic cellular sheets were placed onto a platform inside an incubator set at 37˚C
and 5% CO2. A rod magnet (30 mm) composed of stacked cylinder magnets (2.5 mm
diameter, 5 mm length, pull force =1.8 lbs, SuperMagnet Man) was placed directly
underneath each magnetic cellular sheet on the platform. The platform containing the rod
magnets was fixed to a linear actuator (L16-P Linear Actuator, Firgelli, Victoria BC,
Canada) that was controlled using a custom program built in LABVIEW (National
Instruments). This custom program allowed for controlled cyclic longitudinal translation
of the rod magnets to provide cyclic longitudinal stretch of the magnetic cellular sheets.
Through the program, the frequency, magnitude and time of stretch was controlled. For
this work, 1 Hz and 10% were the frequency and magnitude, respectively. Tissue sheets
were grouped as follows: 3 days of static conditioning on the magnetic template, 7 days
of static conditioning on the magnetic template, 3 days of dynamic longitudinal stretching
using magnetic forces and 7 days of dynamic longitudinal stretching using magnetic
forces.
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Histological Examination
At different time points, spheroids and tissue sheets were collected, fixed and
processed for histological examination [122]. Tissues were embedded into paraffin and
samples were cut into 5 μm sections. Samples were stained using either hematoxylin and
eosin (H&E) or Masson’s Trichrome stain.

Immunohistochemistry
At different time points, spheroids and tissue sheets were collected, fixed and
processed for histological examination [122]. Tissues were embedded into paraffin and
samples were cut into 5 μm sections. Four ECM markers were analyzed: Collagen I,
Collagen IV, Fibronectin and Elastin. The following antibodies were used to stain for
these markers: anti-collagen I antibody (1:200; abcam; ab34710), anti-collagen IV
antibody (1:200; abcam; ab6586), anti-fibronectin (1:200; BD Biosciences; 610077), and
anti-elastin (1:50; abcam; ab23748). Prepped slides were analyzed using a BOND-MAX
automated IHC machine (Leica). An automated Novocastra Bond Polymer Refine
Detection system (Leica; DS9800) was used to stain and detect protein markers in the
tissue samples. Stained samples were imaged using a Nikon AZ100 multizoom
microscope. Results were compared to respective control samples that were only
counterstained for nuclei. Positive protein expression was quantified by measuring the
percent area of the tissue expressing a positive stain and then normalizing to the total area
of the spheroid.
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Western Blot for Collagen and Elastin Protein Quantification
Tissue sheets were collected after 3 and 7 days with and without longitudinal
stretch by magnetic forces. Sheets were then flash frozen for storage. Samples were
placed in lysis buffer and sonicated to extract protein. Protein content was quantified
using spectroscopy and each sample was loaded into gels at 10 µg/well. For primary
antibodies, rabbit polyclonal antibody against collagen I was used to detect collagen I
content (Abcam, ab34710), mouse monoclonal antibody against Hsp47 was used to
detect Hsp47 content (Calbiochem, M16.10A1) and mouse monoclonal antibody against
elastin was used to detect elastin content (Santa Cruz Biotechnology, sc-374638). Bands
were detected by chemiluminescence using peroxidase-conjugated horseradish secondary
antibodies with Amersham’s ECL Prime Western Blotting Detection Reagent. Protein
band intensities were quantified using ImageJ.

Collagen Fiber Alignment
Collagen fiber alignment was performed by measuring the angle of 50 collagen
fibers with respect to the axis of the applied magnetic cyclic longitudinal forces.

Mechanical Testing with Atomic Force Microscopy
After 3 and 7 days, atomic force microscopy (AFM) (Asylum MFP-3D on top of
an Olympus IX81 Spinning Disc Confocal system) was used to determine the Young’s
modulus of statically and dynamically conditioned tissue sheets. A cantilever (~0.12 N/m
spring constant) with a borosilicate spherical tip (5 µm diameter) was used to indent
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tissue sheet samples. The cantilever deflection was measured and converted to a force
measurement using the respective Hook’s spring constant of the tip. The Hertz Model
was used to calculate the Young’s modulus from force-distance curves during data
analysis (MATLAB). Three repeats were used for statistical significance and to confirm
repeatability.

Statistical Analysis
Statistical analysis was performed using an Analysis of Variance (ANOVA) test
to determine if differences were present amongst treatment groups. If differences were
determined from the ANOVA, a post hoc two tailed t-test was used to determine if
significant differences existed between treatments tested. Error bars on graphs represent
the standard deviation from the mean.

4.3 RESULTS
4.3.1 MATURATION OF SPHEROIDS OVER TIME
JMCSs and no iron oxide (NIO) spheroids were formed for three days using
primary rat aortic smooth muscle cells with the hanging drop method [78]. Previous work
and immunohistochemical staining demonstrated that NIO spheroids and JMCSs had the
same ECM contents after three days of formation [37]. Spheroids were incubated for 40
days in cell culture media, with and without ascorbic acid supplementation (50 μg/mL).
Ascorbic acid is a known stimulant of collagen production over time and was used as a
control for our spheroids with and without MNPs. Samples were processed, sectioned and
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immunohistochemically examined after 40 days of incubation [122]. Results
demonstrated that each spheroid type stained positive for collagen I, collagen IV, elastin
and fibronectin ECM proteins when compared to control samples (Figure 4.1a). After 40
days, spheroids are organized, as depicted by their well-defined spherical shape and
cellular organization (Figure 4.1a). The positive expression area of these protein markers
in day 40 spheroids was quantified using ImageJ and normalized to the respective total
area of the tissues (Figure 4.1b). Statistical analyses were not used because only one
sample was analyzed per group for each antibody to confirm expression of the respective
vascular protein. Results demonstrated that the NIO and JMCS D3 spheroids had
comparable positive expression area of collagen I and elastin when compared to day 40
time points, with positive expression areas of 61.96 and 70.84 for NIO day 3 and 57.62
and 68.58 for JMCS day 3 (data not shown). At early time points, while spheroids are
still forming, cells are secreting more protein, protein precursors and ECM components
that can be used to build ECM in attempt to establish structural stability. Collagen and
elastin are critical for this function. As spheroids mature over time, ECM becomes
aligned, deposited and organized according to the systemic needs of the tissue. Over time,
spheroids optimize their structure and do not rapidly secrete proteins and their precursors,
like at earlier time points, because they become structurally stable without the presence of
physical forces or environmental cues [11, 29]. This is the cause for the small increase or
drop in positive area of protein expression in day 40 spheroid for collagen and elastin,
when compared to day 3. Interestingly, there was an increase in positive area of protein
expression in all groups for collagen IV and fibronectin when comparing day 40
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spheroids to day 3 spheroids. Collagen IV, in addition to collagen I, has been shown to be
important for structural stability in vascular tissue and fibronectin is critical for cell
adhesion, ECM attachments and cell proliferation during maturation of tissue [168, 169].
An increase in collagen IV and fibronectin expression in spheroids over time would be
expected to accommodate the needs for structural stability and organization as the tissue
develops and matures over time [170].
Further, the positive area stains observed in JMCSs spheroids at day 40 were
comparable to the NIO group supplemented with ascorbic acid, which is a known
stimulant of ECM production [26, 171, 172]. Additionally, JMCSs supplemented with
ascorbic acid had higher expression of all proteins at the day 40 time point, suggesting a
synergistic effect between iron oxide MNPs and ascorbic acid for ECM production. This
corresponds to our previous work where iron oxide MNPs were shown to stimulate ECM
production over time, when compared to spheroids without iron oxide MNPs and
spheroids without iron oxide MNPs supplemented with ascorbic acid [37]. While
ascorbic acid has been known to enhance collagen production through ascorbatedependent hydroxylation, its effect on elastin is not completely understood. A study in
1980 by de Clerck and coworkers used 2D cultures of smooth muscle cells and showed
that the deposition of insoluble elastin was inversely proportional to ascorbic acid
concentration due to over hydroxylation of tropoelastin, which is the precursor to
insoluble elastin [171, 173]. In 2013, a study by Derricks and coworkers observed a
dramatic increase in elastin production from primary rat neonatal pulmonary fibroblasts
in response to ascorbic acid in 3D cell-Gelfoam constructs [174]. From day 14 to 21,

117

ELISA results showed that elastin deposition increased 4.5 fold in the ascorbic acid
treated 3D cell-Gelfoam constructs when compared to no ascorbic acid treated tissues
[174]. q-PCR results supported these results as protein expression increased from 1.5 fold
to 8.8 fold over the same time period for ascorbic acid treated tissues [174]. At the same
time, no significant elastin deposition was observed in 2D cultures of the same cell type
over time [174]. These results indicate that the 3D nature of the cell-ECM environment
will direct the cellular response to ascorbic acid. While ascorbic acid has not been shown
to significantly induce elastin production in 2D cultures of smooth muscle cells, here we
have shown that cellular spheroids, which are 3D cell cultures, will respond to treatment
with ascorbic acid (50 μg/mL). Based on work by Derricks and coworkers, we can
attribute the cellular response in the spheroids from ascorbic acid to the 3D architecture
of the spheroids.
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b

Figure 4.1. Immunohistochemistry Staining of Spheroids Over Time. (a) Spheroids containing
iron oxide MNPs and spheroids without MNPs were immunohistochemically examined for
collagen I, collagen IV, elastin and fibronectin after 40 days of incubation in cell culture media.
Spheroids with and without MNPs were also incubated in media supplemented with ascorbic acid,
a known stimulant of collagen production. When compared to their respective controls, each
spheroid type demonstrated positive stains for each ECM marker. Day 40 spheroids have
demonstrated preferential cellular organization, given by the spherical geometry. (b) Positive
expression area of collagen I, collagen IV, elastin and fibronectin was quantified using ImageJ and
normalized to respective control tissues. (NIO=No iron oxide spheroids; JMCS=Janus magnetic
cellular spheroids; AANIO=Ascorbic acid no iron oxide spheroids; AAJMCS=Ascorbic acid janus
magnetic cellular spheroids).
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In previous work, we have demonstrated that vascular smooth muscle cells
maintain viability and cellular phenotype when formed into JMCSs [78]. When combined
with long term viability, positive expression for vascular ECM markers over 40 days is a
critical step for the development of viable and functional tissue engineered constructs.
Future work will include additional time points to thoroughly characterize the
development of the ECM network in developing spheroids. Further, ECM production will
be studied in spheroids composed of fibroblasts and endothelial cells, which can lend
insight into the role and importance of communication between the different vascular cell
types.
4.3.2 DYNAMIC AND STATIC MATURATION OF TISSUE SHEETS
Tissue Sheet Histological Examination and ECM Production
Multiple groups are utilizing spheroids to build larger and more complex tissues
for various applications [11, 12, 38, 59, 69, 136, 175, 176]. Magnetic force based tissue
engineering is an attractive option for biofabrication because tissues can not only be
patterned and aligned from a distance, but also their fusion accelerated over time due to
increased contacts created due to the magnetic forces [36, 76-78, 122, 125]. Here,
magnetic forces were used to pattern JMCSs into tissue sheets and to promote their fusion
over time by promoting active contact between adjacent spheroids (Figure 4.2a). After
10 days of fusion, tissue sheets were either statically maintained on a magnetic template
or dynamically conditioned using cyclic longitudinal stretch mediated by magnetic forces
(Figure 4.2b). A custom program, built using LABVIEW, allowed for precise control
over the frequency, magnitude and time of conditioning.
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Figure 4.2. Processing and Post-Processing of Tissue Sheets Composed of
JMCSs. (a) Schematic depicting tissue sheet processing. 1,000 JMCSs were
formed for three days using the hanging drop method. Spheroids were then
seeded into a 6 well plate with a glass slide on the inside bottom surface.
Magnets attached to the bottom of the 6 well plate allow for patterning of the
spheroids into a rectangular sheet. Sheets were allowed to fuse for 10 days.
(b) Schematic depicting tissue sheet post-processing. The magnetic templates
were removed from the bottom of the well plates containing fused tissue
sheets. The well plates containing the fused sheets were placed onto a
platform inside an incubator. Using a linear actuator, an array of magnets was
translated in a cyclic, uniaxial direction beneath the fused tissue sheets. The
device allows for precise control over frequency, magnitude of stretch and
duration of conditioning.
Gauvin and coworkers cultured tissue sheets using a self-assembly approach over
35 days with dermal fibroblasts supplemented with ascorbic acid. The tissue engineered
sheets were dynamically conditioned using cyclic longitudinal strain using 1 Hz
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frequency, 10% magnitude and 72 hours of conditioning. When compared to statically
cultured tissues, dynamically conditioned tissues demonstrated increased collagen I and
elastin production using western blot. Additionally, the axial ultimate tensile strength
increased by 1.856 fold when compared to statically cultured tissues and the axial
modulus increased by 1.724 fold when compared the statically cultured tissues. To be
consistent with the literature and to simulate physiological conditions, our study used 1
Hz, 10% and 24 hours per day as the chosen frequency, magnitude and time of
conditioning, respectively.
Here, tissues sheets were collected for analysis after 3 and 7 day time points.
Histological examination using an H&E stain demonstrates the presence of cell nuclei
throughout statically and dynamically conditioned sheets at the 3 and 7 day time points
(Figure 4.3). In previous work, live/dead staining demonstrated that the tissue sheets
contain a large population of viable cells with only a small portion of dead cells after 3
days of fusion. The Masson’s Trichrome stain demonstrates the presence of collagenous
ECM throughout the statically and dynamically conditioned groups after 3 and 7 days
(Figure 4.3). Results demonstrate that aligned collagenous fibers along the stretching
direction are visible in the tissue sheets that were dynamically conditioned for 7 days,
which indicates that the cyclic longitudinal conditioning mediated by magnetic forces is
causing ECM remodeling in response to the dynamic forces applied. The development of
a cross-linked collagenous network is critical for the success of a scaffold free tissue
engineered construct, as it provides for structural integrity and acts as a scaffold for
cellular organization [57, 154, 165, 177]. Iron has been shown to effect collagen on the
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cellular level by up-regulating collagen gene expression and also at the extracellular level
by promoting and stabilizing collagen crosslinking [155]. Here, the dynamic conditioning
of the tissue sheets mediated by magnetic forces is providing the cues for maturation.
Additionally, the ions being released from the degradation of the iron oxide MNPs inside
the tissue sheets over time could be up-regulating collagen production and promoting
crosslinking of collagen produced by the tissues.

Figure 4.3. Tissue Sheet H&E and Masson’s Trichrome Staining. Fused tissue sheets
composed of JMCSs were either statically maintained on a magnetic template or dynamically
conditioned using magnetic forces. After 3 and 7 day time points, tissue sheets were collected,
fixed and processed for histological examination. The H&E stain demonstrates the presence of
cell nuclei throughout the statically and dynamically conditioned groups after 3 and 7 days. The
Masson’s Trichrome stain demonstrates the presence of collagenous ECM throughout the
statically and dynamically conditioned groups after 3 and 7 days.
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Results of immunohistochemical staining demonstrate that tissue sheets produce
ECM over time, as statically and dynamically conditioned tissue sheets stained positive
for collagen I, collagen IV, elastin and fibronectin at day 3 and day 7 time points (Figure
4.4a). The positive expression area of these protein markers in day 7 tissue sheets was

Figure 4.4. Tissue Sheet Immunohistochemistry Staining. (a) Fused tissue sheets
composed of JMCSs were either statically maintained on a magnetic template or dynamically
conditioned using magnetic forces. After 7 days, tissue sheets were collected, fixed and
processed for histological examination. When compared to the control tissue samples, static
and dynamic tissues all stained positive for collagen I, collagen IV, elastin and fibronectin.
(b) Positive expression area of collagen I, collagen IV, elastin and fibronectin was quantified
using ImageJ for day 7 statically and dynamically conditioned tissues.
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quantified using ImageJ and normalized to the respective total area of the tissues (Figure
4.4b). Statistical analyses were not used because only one sample was analyzed per group
for each antibody to confirm expression of the respective vascular protein. For statically
conditioned tissue sheets, results showed positive expression areas of 70%, 73%, 13%,
and 41% for collagen I, collagen IV, elastin and fibronectin, respectively. Results
demonstrated that dynamically conditioned tissue sheets had positive expression areas of
75%, 75%, 20% and 41% for collagen I, collagen IV, elastin and fibronectin,
respectively. Dynamic conditioning did not increase collagen production based on IHC
studies, as the statically conditioned tissues demonstrated comparable levels of
expression. These results are consistent with spheroid studies, where there was high
expression of collagen I, collagen IV, fibronectin and increased expression of elastin.
Expression of these proteins after the spheroids have been patterned and fused into tissue
sheets demonstrates that the tissue sheet processing step stimulates production of these
key vascular ECM proteins.
Dynamic mechanical conditioning has been used to induce collagen and elastin
production in 2D cultures and 3D tissue constructs [56, 81, 82, 178]. Gauvin and
coworkers used cyclical longitudinal stretching to induce anisotropy and improve tensile
properties of engineered tissues constructed with human dermal fibroblasts. Histological
examination confirmed organized collagen and western blot confirmed the presence of
collagen and elastin content within the tissues, but this was not quantified. Here, cyclical
longitudinal stretching, mediated by magnetic forces, of tissue sheets composed of
primary rat aortic smooth muscle cells was used to induce collagen and elastin production
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as a post-processing technique for maturation. Western blot was used to probe for
collagen I, Hsp47 and elastin content in the tissue sheets. For this study, one western blot
was performed to confirm protein content and gain an understanding of the relative
protein contents. When compared to day 3 static sheets, results demonstrated a 2.40 fold
increase in collagen content for day 7 static sheets, a 3.03 fold increase in collagen
content for day 3 dynamic sheets and a 3.09 fold increase in collagen content for day 7
dynamic sheets (Figure 4.5a). Heat shock protein 47 is a collagen binding glycoprotein
localized in the endoplasmic reticulum and is a chaperone that mediates collagen
maturation [179]. When compared to day 3 static sheets, results showed a 1.10 fold
increase in Hsp47 content for day 7 static sheets, a 4.84 fold increase in Hsp47 content
for day 3 dynamic sheets and a 8.50 fold increase in Hsp47 content for day 7 dynamic
sheets (Figure 4.5a). When probed for elastin and compared to day 3 static sheets, results
showed a 1.15 fold increase in elastin content for day 7 static sheets, a 20.4 fold increase
in elastin content for day 3 dynamic sheets and a 35.3 fold increase in elastin content for
day 7 dynamic sheets (Figure 4.5a). The respective protein bands from the western blots
are depicted in Figure 4.5b. These results indicate that the dynamic longitudinal
stretching, mediated by magnetic forces, caused an increase in collagen production over
time when compared to statically cultured controls. Future work will include quantifying
collagen cross-linking, analyzing ECM gene expression of tissues that are dynamically
conditioned and including longer time points.
O’Callaghan and coworkers dynamically stretched VMCSs 10%-16% of the
original length for 5 days at 1 Hz and results demonstrated that collagen production in
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media was 12% for statically conditioned cells and 18% for dynamically conditioned
cells [178]. Dynamic conditioning of cell sheets composed of neonatal dermal fibroblasts
actually showed less collagen production (% of total protein) when compared to statically
cultured tissue sheets (10% stretch vs. 13% static), but no differences in collagen
concentration. Here, total collagen content was quantified at days 1, 3 and 7 in the media
collected from statically and dynamically cultured tissue sheets (Figure 4.5c). When
normalized to day 1, day 3 and day 7 statically conditioned tissue sheets had collagen
contents that were 99% and 94%, respectively. For dynamically conditioned tissue sheets,
collagen contents at the day 3 and 7 time points were 110% and 113%, respectively,
when normalized to day 1. At the day 3 and day 7 time points, the dynamically
conditioned tissues had significantly higher collagen contents than the static controls
(p<0.05). These results support that dynamic conditioning mediated by magnetic forces is
inducing collagen production and reorganization.
b

a
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Figure 4.5 Insoluble and Soluble Protein Content in Tissue Sheets. (a) Quantification of
collagen I, Hsp47 and elastin content in tissue sheets with and without cyclic longitudinal
stretching mediated by magnetic forces. Results are normalized to day 3 static tissue sheets.
(b) Representative protein and GAPDH bands from western blots. (c) Normalized soluble
collagen content in the media of statically and dynamically conditioned tissue sheets after 3
and 7 days. (‘*’ and ‘+’ indicate statistical significance).

Figure 4.6. Tissue Sheet Mechanical Properties. The Young’s modulus tissue sheets
were determined using atomic force microscopy. Results demonstrate that the
dynamically conditioned tissue sheets had significantly higher Young’s modulus values
at both time points when compared to statically conditioned controls. (‘*’ and ‘+’ indicate
statistical significance).
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Tissue Sheet Mechanical Properties
The Young’s modulus of tissue sheets that were subjected to cyclic longitudinal
stretching mediated by magnetic forces were compared to statically maintained tissue
sheets at 3 and 7 day time points. Here, 1 Hz frequency, 10% magnitude and 24 hours per
day stretching were used as the conditions based on physiological demands [2, 81, 82].
Results demonstrate that the day 3 dynamically conditioned tissue sheets had a Young’s
modulus (32 kPa) that was significantly greater than its statically conditioned counterpart
(22 kPa) (Figure 4.6). Results also show that the day 7 dynamically conditioned tissue
sheets had a Young’s modulus (39 kPa) that was significantly greater than its statically
conditioned counterpart (27 kPa) (Figure 4.6).

Fiber Alignment in Tissue Sheets
Physiologically, elastic fibers and contractile SMCs are responsible for vascular
mechanical strength and linear elastic behavior at low pressures [165]. Aligned collagen
fibers are heavily recruited at greater than physiological blood pressures. At these levels,
the collagen fibers cause a non-linear stress-strain relationship and are responsible for the
high ultimate tensile strength, stiffness, and elastic modulus observed in native arteries
[3, 57, 165, 180]. Here, collagen fiber alignment was observed in the direction of the
applied magnetic cyclic longitudinal stretching forces for day 7 samples when compared
to day 3 statically conditioned samples (Figure 4.7a). To quantify collagen fiber
alignment, the angle of the fibers with respect to the applied force was measured. Results
demonstrated that 37 of the 50 collagen fibers measured had angles that were within 10
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degrees of the axis of the applied magnetic force, demonstrating fiber alignment from the
dynamic magnetic force maturation (Figure 4.7b).

Figure 4.7. Collagen Fiber Alignment. (a) After 7 days of cyclic longitudinal
stretching mediated by magnetic forces, collagen fibers were observed, when
compared to 3 days of static conditioning. (b) The angle of 50 collagen fibers was
measured with respect to the applied magnetic forces and results showed that 37 of
the 50 fibers measured were within 10 degrees of the axis of the applied forces.
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4.4 DISCUSSION
Recently, cellular spheroids have been employed to biofabricate vascular
constructs, due to their ability to produce ECM over time and their three dimensional
nature, which more accurately mimics native tissues. When developing a tissue
engineered vascular construct, it will be essential that the tissues contain key vascular
ECM proteins like collagen I, collagen IV, elastin and fibronectin [180]. These proteins
are important for structural integrity, cellular organization and functionality of the tissues.
Collagen I is present in all layers of blood vessels and is critical for stability of tissues
[170]. It has a high tensile strength and elastic modulus to handle forces above
physiological conditions. Mutations of genes affecting the col1 gene results in diseases
like osteogenesis imperfecta and Ehlers-Danlos Syndrome Type VIIA and B [170].
Collagen IV is a major structural protein of basement membranes and over time will form
the structural skeleton of the developing tissue [170]. Elastin is distensible and provides
elasticity to distribute stress throughout vessel walls and collagen fibers. Fibronectin is
essential in vessel development and plays a critical role in facilitating cell movement
during early migratory events in cell wall formation [170]. Fibronectin’s continued
expression over time during maturation suggests its importance in maintaining tissue
homeostasis [170]. Our immunostaining results suggest continued expression of all these
key vascular proteins in both individual spheroids and tissue sheets over time. Moreover,
there seems to be a synergistic effect between iron oxide magnetic nanoparticles and
ascorbic acid for ECM production in individual spheroids, which was previously
observed using a hydroxyproline assay [37].
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The mechanical properties of native arteries and veins are known and maturation
methods have been used to develop tissues that mimic those mechanical properties [4, 56,
57, 82, 181]. Scaffold free fabrication methods using spheroids and tissues composed of
spheroids are expected to have lower mechanical properties due to the need of
endogenous production of ECM. Mechanical analysis of human mesenchymal stem cell
spheroid demonstrated that the incorporation of gelatin microparticles into spheroids
yielded an average modulus that was more than 4 times greater than spheroids without
microparticles, which can play a role in in vitro directed differentiation strategies [182].
Our results indicate that the cyclic longitudinal stretching mediated by magnetic forces
provided the mechanical cues necessary to stimulate cell and ECM remodeling and
reorganization according to the loads applied.
Further, dynamic conditioning was shown here to increase collagen, Hsp47 and
elastin production during the 7 day period study using western blot. While only one
western blot was performed for each protein, results suggest dynamic conditioning is
causing the increase in protein content. This is the first known report of using magnetic
forces to induce maturation in tissue sheets that includes collagen and elastin production.
Western blot data showed that the GAPDH content for statically cultured tissues is lower
than dynamically conditioned tissues. These results suggest that when compared to
statically maintained tissue sheets, dynamic conditioning may be playing a role in
maintaining expression of this key housekeeping protein that regulates glycolysis,
transcription and nuclear function in the cells of the tissue sheets. Future work will
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include western blot repeats for statistical significance and to quantify other key vascular
protein contents.
In addition to enhancing protein content, the dynamic conditioning induced
collagen crosslinking based on the appearance of aligned fibers. The alignment of the
collagen fibers was a factor in the increased modulus of elasticity that was observed from
dynamic longitudinal stretching. Weidenhamer and coworkers demonstrated collagen
fiber alignment in tissue sheets composed of neonatal dermal fibroblasts that were
subjected to 5% strain, 0.5 Hz for 3 weeks [183]. Stretched tissue sheets observed axial
alignment of actin and collagen with fibers being all fibers being within 15 degrees of the
axis of applied strain [183]. Gauvin and coworkers also observed alignment of collagen
and actin in stretched tissue sheets, further demonstrating the use of mechanical
stretching for the alignment and organization of ECM [81].
In our previous work, it has been show that these tissue sheets, composed of fused
JMCSs, can be wrapped around a silicone mandrel to form a tissue tube during the
processing step [78]. Understanding the mechanics of spheroids and tissue constructs
made from spheroids during the post-processing step will be important moving forward.
Continuing to develop post-processing methods and understanding the mechanisms
behind them will allow for tissue engineered constructs composed of spheroids to become
comparable to native tissues in terms of mechanical properties and ECM content. Future
work will include burst pressure and suture retention strength testing on tissue tubes that
will be mechanically conditioned using magnetic forces. Post-processing conditions will
be varied in terms of frequency of stimulation, magnitude of stretch and time.
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4.5 CONCLUSIONS
Developing post-processing methods for enhancing ECM deposition and
mechanical properties of tissues composed of cellular spheroids will be critical in order to
be functional tissue engineered constructs. We demonstrated that over 40 days, JMCSs
will continue to express collagen I, collagen IV, elastin and fibronectin, which are key
vascular ECM proteins. Further, tissue sheets composed of JMCSs will continue to
produce these key proteins, indicating that the tissue processing step into sheets may
enhance ECM production. Quantitative results demonstrate that cyclic longitudinal
stretching of the tissue sheets mediated by magnetic forces enhances the stiffness of the
tissues over time, enhances collagen and elastin production, and collagen alignment in
response to the forces applied. These studies highlight the use of magnetic force based
tissue engineering and validate its potential for biofabrication methods.
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CHAPTER 5
CONCLUSIONS
Overview
The work in this thesis demonstrates that spheroid composition and magnetic
forces are critical to the fusion of spheroids over time. This research is significant
because we developed new methods to safely integrate nanotechnologies with tissue
engineered vascular tissue to accelerate fusion and maturation in a unique manner using
magnetic forces. This work took advantage of two emerging areas in research—
nanotechnology and tissue engineering. The results from this work are expected to lead to
an understanding of what conditions and cues are necessary to accelerate the fusion and
maturation of tissues using physiological forces. Further, this could be a change in
paradigm when related to tissue engineering approaches because we showed that more
collagen does not result in enhanced fusion. This fundamental understanding is expected
to provide a strong theoretical and methodological foundation for the development of
new tissue engineering technologies with vascular tissue engineering applications.

Limiting Magnetic Nanoparticle Interaction with Cells Using the Janus Method
A variety of methods that utilize internalization of MNPs into cells have been
investigated

to

integrate

MNPs

with

tissue

engineering,

including

MNP

conjugation/binding to the cell [89, 92, 93], cellular internalization [98, 114-116], and
mixing MNPs within the ECM [88, 114, 117]. However, all of these approaches are
limited to short term studies due to adverse effects related to MNP internalization [88-90,
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116, 121] into cells. For this research, a novel method to incorporate iron oxide magnetic
nanoparticles into cellular spheroids was used, called the Janus method, which was
developed in our lab (Figure 5.1). This technology is innovative because upon spheroid
fabrication, two separate domains are created: cells and MNPs. The limited interaction
between cells and MNPs allows high viability and phenotypic expression to be
maintained over time, which is essential for tissue engineering applications [37, 76-78].
Further, our research has shown that these Janus magnetic cellular spheroids are
candidates for tissue engineering larger constructs [37, 77].

Figure 5.1. Incorporating Iron Oxide MNPs into Cellular Spheroids. Janus magnetic
spheroid structures do not exhibit the cytotoxic affects associated with MNP internalization
common to dispersed and uptake methods by separating MNPs and cells into segregated
and distinct regions. The combination of MNPs (black), cells (pink), and ECM (collagen,
blue) into segregated regions decreases cellular toxicity related to MNPs by decreasing
interactions with cells.

A limitation of using MNPs in tissue engineered constructs is the uncertainty of
the influences and fate of iron oxide MNPs over time. Work has shown that excess
amounts of iron in the body can cause disorders such as thalassemias, hemochromatosis,
anemia and fibrosis [184]. To address these issues, work in our lab has been underway to
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accelerate the degradation of iron oxide in cellular spheroids [77]. The optimal iron oxide
MNP concentration, particle type, particle shape, polymer coating or functionalization
will have to be determined moving forward for tissue engineering applications. One more
limitation is how to address any potential unwanted activation of endothelial and smooth
muscle cells by the particles.

Promoting Active Contact Between Magnetic Cellular Spheroids Using Magnetic
Forces
Conventional tissue assembly and fabrication methods include cell printing, cell
sheet techniques, and patterned molds [11, 26, 29, 62]. These non-magnetic methods
spatially orient the cells and tissues into a desired position through passive contact, but do
not promote active contact for accelerated tissue fusion. Due to this, engineered tissues
are not homogenous or cohesive and problems arise when handling the tissues. It is
known that when two spheroids are placed into contact that they will fuse into a single
cohesive tissue over time [34, 58, 71, 150]. Tissue fusion is a critical process for the
development and maturation of tissues [34, 58, 150]. Here, magnetic forces were used to
pattern, align and promote active contact between magnetic cellular spheroids in order to
accelerate the tissue fusion process [37, 78]. Data has shown that when Janus spheroids
are patterned into rings and exposed to magnetic forces, they fused into a homogenous
and cohesive ring after 48 hours (Figure 5.2). Rings composed of spheroids without
MNPs and magnetic forces showed minimal fusion and fell apart upon handling. This
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Figure 5.2. Magnetic Forces Mediate the Fusion of JMCSs. Janus MNP and MNP-free
control spheroids were each seeded into silicone ring molds and allowed to fuse for 48
hours. JMCS ring molds were exposed to magnetic forces, while MNP-free control ring
molds were not. Results showed that MNP-free control rings experienced minimal fusion,
as individual spheroids were visible after 48 hours. Results demonstrated that, over 48
hours, magnetic forces mediated the fusion of JMCSs into a fused tissue ring. Scale bars =
1000 μm.

technique is innovative because it focuses on using magnetic forces to actively promote
fusion of novel magnetic cellular spheroids.
A limitation of using magnetic forces and MNPs to build larger tissues is the
potential for the development of necrotic areas within the tissue. While the MNPs have
been shown to have minimal toxic effects in individual spheroids, the viability of larger
and more complex tissues decreases with size, due to diffusion limits.

Spheroid Composition Influences Fusion
Spheroid composition is critical to the fusion process and manipulation of the
composition was utilized to study fusion kinetics of JMCSs mediated by magnetic forces.
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Results showed that ECM content and cell number play a key role in mediating the fusion
of cellular spheroids into complex tissues (Figure 5.3). Results showed that iron oxide
MNPs in JMCSs stimulate collagen production, which is critical for scaffold free tissue
engineering. Further, results demonstrated that cell-cell and cell-ECM interactions in
spheroids are critical in determining the fusion dynamics of tissues. This new
understanding of JMCS composition and its influence on fusion can be applied to the
fabrication of larger tissues, like blood vessels. This could be a change in paradigm when
related to tissue engineering approaches because more collagen does not result in
enhanced fusion.

Figure 5.3. Varying Spheroid Composition Influences Ring Fusion Over Time.
Visual analysis of ring fusion confirms that collagen content plays a significant
role in tissue fusion and compaction, with decreases in fusion and compaction
becoming evident with increasing collagen concentrations.
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A limitation of manipulating spheroid content (collagen and cell number) is that
the influence will vary with the type or types of cells used. While this work demonstrates
the effects of spheroid content on fusion and cell intermixing for primary rat aortic
smooth muscle cells, endothelial and fibroblast cells would also have to be examined for
vascular tissue engineering applications.

Cyclic Longitudinal Stretching Using Magnetic Forces
Fabrication of functional tissue engineered constructs with appropriate cell
densities, ECM contents, and mechanical properties that mimic native tissues still remain
a challenge due to the lack of understanding associated with tissue fusion and maturation
mechanisms [11, 58]. Cyclic radial stretching and pulsatile flow have been shown to
enhance ECM production (collagen) and enhance mechanical properties, but the
parameters for optimal maturation (frequency, magnitude, time of stimulation) have not
been defined [56, 57, 82, 83, 85]. These studies overlook another force experienced by
blood vessels, longitudinal stretch. Almost all arteries in vivo experience longitudinal
strain (axial), with magnitudes ranging from 40% to 65% [162-164]. Studies have shown
that static and cyclic longitudinal loading of tissue engineered constructs can accelerate
extracellular matrix deposition and rapidly improve mechanical properties, both of which
are critical for the development of a suitable tissue engineered replacements [81, 86].
Magnetic nanoparticles have been incorporated into cellular spheroids and aligned and
patterned using magnetic force assembly [88, 90, 92, 93, 97, 151, 152], but the use of
magnetic forces for accelerating maturation of vascular constructs has not been studied.
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Here, cyclic longitudinal stretching of tissues composed of Janus magnetic
cellular spheroids (JMCSs) was mediated by magnetic forces and used as a postprocessing method for enhancing ECM deposition and mechanical properties (Figure
5.4). First, we demonstrated that over 40 days, JMCSs will express collagen I, collagen
IV, elastin and fibronectin, which are key vascular ECM proteins. Next, we showed that
fused tissue sheets composed of JMCSs continue to produce these key proteins when
exposed to magnetic forces. Quantitative results demonstrate that cyclic longitudinal
stretching of the tissue sheets mediated by magnetic forces increases the Young’s
modulus, enhances collagen production and induces collagen fiber alignment over 7 days,
when compared to statically conditioned controls. These findings indicate that cyclic
longitudinal stretching of tissues using magnetic forces has the potential to be used for
maturation.
A limitation of this approach to magnetic maturation is the limited knowledge of
what parameters lead to optimal tissue maturation. The most optimal frequency,
magnitude, magnetic field strength and time of stimulation must be determined for each
application and tissue type. One interesting thought to consider is: “how much tissue
maturation is enough?” This question opens the door to many other questions moving
forward. Do the mechanical properties have to be exactly the same as native tissue? Does
the collagen content have to be less than, the same as, or more than native tissue? Will
the body be able to play a role as bioreactor? Future in vitro studies, modeling and
translation to animal models will help address these questions.
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Figure 5.4. Processing and Post-Processing of Tissues Using Magnetic Forces.
Magnetic templates were used to pattern spheroids into sheets and mediate their fusion with
enhanced contacts. After 10 days, an actuator was used to induce cyclic uniaxial
longitudinal stretch on the MNP containing sheets. Our results demonstrated increased
mechanical properties, enhanced protein content and ECM alignment.

Concluding Remarks
Here, spheroid composition was manipulated, by varying ECM and cell contents,
in order to study the resulting effects on JMCS fusion mediated by magnetic forces. Next,
the influence of iron oxide MNPs on ECM production in JMCSs was studied over time.
Further, magnetic sheets composed of JMCSs were fabricated and their maturation
mediated by cyclic longitudinal stretching using magnetic forces. The objective of this
work was to determine the mechanisms associated with the fusion and maturation of
JMCSs and tissues composed of JMCSs. The hypotheses driving this work were that
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spheroid composition dictates their fusion and that magnetic forces can be utilized to
dynamically condition tissues composed of JMCSs for maturation.
Results demonstrated the critical importance of magnetic forces for promoting the
fusion of JMCSs, when compared to JMCSs not exposed to magnetic forces. Further,
results demonstrate the critical role of cell-cell and cell-ECM interactions for mediating
cellular spheroid fusion over time. Results showed that the addition of iron oxide
magnetic nanoparticles in JMCSs caused a significant increase in collagen production,
when compared to no iron oxide controls. Quantitative results demonstrate that cyclic
longitudinal stretching of tissue sheets mediated by magnetic forces increases the
Young’s modulus, enhances ECM production and induces collagen fiber alignment over
7 days, when compared to statically conditioned controls.
This project focused on understanding the fusion and maturation of Janus
magnetic cellular spheroids mediated by magnetic forces. These findings are expected to
provide a strong theoretical and methodological foundation for the development of new
tissue engineering technologies. While this project is still new, there is a lot of potential
for further exploration and experimentation to learn more about these mini-tissues and
their applications.
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CHAPTER 6
FUTURE RECOMMENDATIONS
Based on the literature review and research presented in this document, future
recommendations are described below:

6.1 Determining Optimal Spheroid Composition for Building Tissues
The work presented in this thesis has a focus in understanding the influences of
collagen content and cell density on fusing magnetic cellular spheroids over time. For the
spheroids used in this work, the collagen had been added during the fabrication process
and enhanced spheroid formation over the course of three days. Through this work, we
found that low collagen contents and high cell densities promoted the most fusion and
cellular intermixing between adjacent spheroids over time when mediated by magnetic
forces [37]. However, initial work in our lab has shown that building tubular tissues with
magnetic cellular spheroids required higher collagen contents to fabricate a structure that
could stand alone without collapsing on itself, when compared to low collagen contents
[78]. Other groups have shown that using just cells and the endogenous extracellular
matrix that they produce is sufficient to produce tissues with measurable mechanical
properties [53, 54]. Using human aortic smooth muscle cells, Gwyther generated tissue
rings, which formed after 24 hours, and was able to place them into contact on a silicon
mandrel to form a tubular tissue [53, 54]. However, even after 7 days, ring margins were
still visible, indicating more time is required for complete fusion.
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To improve upon the work in our lab for building vascular tissues using cellular
spheroids, the following is recommended. Janus magnetic cellular spheroids should be
fabricated with just cells and iron oxide magnetic nanoparticles. Our work has shown that
the spheroids will produce their own collagen over time, with more than double the
collagen content after 20 days and more than 6 times the collagen content after 40 days.
The addition of exogenous matrix should be eliminated because many groups already
fabricate spheroids without it. While we have shown the collagen production over time in
individual spheroids, it would be interesting to see how much collagen is produced in
larger tissues composed of spheroids over time. Due to cell adhesion, cell intermixing
and signaling through cytokines, it can be expected more collagen is produced in tissues
composed of spheroids when compared to individual spheroids over time.
Additionally, it is recommended that attempts are made to pattern spheroids after
a day of formation. Currently, spheroids in our lab are left to form in a hanging drop for
three days to achieve the desired spherical shape. Work has been shown by Morgan and
coworkers that pre-cultured spheroids (1, 4 and 7 days), which are more mature, fuse
more slowly over time when compared to spheroids that were not pre-cultured prior to
being placed into contact [185]. Based on this work, it seems that the faster the forming
spheroids are placed into contact, the more quickly they will fuse into a cohesive and
homogenous structure. For example, if tissue sheets are desired for tube fabrication,
spheroids should be formed for 24 hours in the hanging drop, then seeded onto a
magnetic template to fuse into a sheet for 24 hours and then wrapped around a mandrel to
form a tube. This technique will ensure the most rapid fusion and minimize tissue gaps.
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6.2 Elastin Synthesis in Spheroids Over Time
While a focus of this thesis was on quantifying collagen content in spheroids over
time, another important extracellular matrix protein for vascular tissues is elastin. Elastin
is distensible and provides elasticity to distribute stress throughout vessel walls and
collagen fibers. Inducing in vitro production of elastin in tissue engineered constructs will
be critical to fabricating tissues that mimic native tissues and is considered the holy grail
of tissue engineering. Our lab has been investigating the use of ascorbic acid (50 µg/mL)
on collagen production in individual spheroids and we have seen that it does in fact
induce collagen synthesis over 40 days when compared to spheroids without ascorbic
acid treatment [37]. Histological examination using immunohistochemistry has shown
increases in positive expression of elastin over time in spheroids with ascorbic acid
treatment, when compared to no treatment. Even more, there seems to be a synergistic
effect between ascorbic acid and iron oxide magnetic nanoparticles for the production of
elastin.
In 2013, a study by Derricks and coworkers observed a dramatic increase in
elastin production from primary rat neonatal pulmonary fibroblasts in response to
ascorbic acid in 3D cell-Gelfoam constructs [174]. From day 14 to 21, ELISA results
showed that elastin deposition increased 4.5 fold in the ascorbic acid treated 3D cellGelfoam constructs when compared to no ascorbic acid treated tissues [174]. q-PCR
results supported these results as protein expression increased from 1.5 fold to 8.8 fold
over the same time period for ascorbic acid treated tissues [174]. At the same time, no
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significant elastin deposition was observed in 2D cultures of the same cell type over time
[174]. These results indicate that the 3D nature of the cell-ECM environment will direct
the cellular response to ascorbic acid. While ascorbic acid has not been shown to
significantly induce elastin production in 2D cultures of smooth muscle cells, here we
have shown that cellular spheroids, which are 3D cell cultures, will respond to treatment
with ascorbic acid (50 μg/mL). Based on work by Derricks and coworkers, we can
attribute the cellular response in the spheroids from ascorbic acid to the 3D architecture
of the spheroids. Future work should include quantification of elastin production over
time in individual spheroids and tissues composed of spheroids. Even more, the influence
of ascorbic acid on elastin production must be examined.

6.3 Magnetic Bioprinting of Magnetic Cellular Spheroids
Mechanical testing is critical for predicting the success of tissue engineering
vasculature for handling the forces experienced in vivo. The battery of tests for vascular
tissues includes burst pressure testing, compliance testing and suture retention strength
testing. To be able to perform these tests, the tissue construct to be test must meet
minimum size requirements (length and diameter) in order to fit into the respective
testing devices. To fabricate a tissue tube composed of Janus magnetic cellular spheroids
of relevant size, it requires at least 8,000 spheroids. This translates to 160 million cells, 78 hours of lab work with three students and a lot of consumables used. If there are no
setbacks or errors, this will yield one tube. For statistically significant data, three tubes
would be required, so a means to upscale and automate is necessary.
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To address this a magnetic bioprinter should be designed and fabricated with a
robotic arm that has a magnet on the end, which will have the ability to attract a
cell/MNP solution or spheroids with the magnetic field ‘on’ and be able to move the arm
in the X, Y and Z planes to accurately place the spheroid and print it by simply turning
‘off’ the field. The printer could be used to dispense a cell/MNP solution to fabricate
spheroids or dispense preformed spheroids into desired positions with high precision and
accuracy. Being able to load a cell/MNP solution or spheroids into a bioprinter will allow
for more spheroids or constructs to be produced in a given amount of time due to the
automation. Further, automation will reduce risk of human error and contamination.
Whatley and coworkers used a homemade bioprinter to dispense controlled
amounts of endothelial cells loaded with iron oxide magnetic nanoparticles into agarose
molds using magnetic forces [68]. After three days of formation, spheroids were shown
to viable and could be patterned on predefined magnetic templates [68]. Perhaps this
concept can be translated to dispense cell solutions with iron oxide magnetic
nanoparticles into hanging drops on petri dishes guided by magnetic forces.
Souza and coworkers developed a vascular ring assay for smooth muscle
contractility using magnetic 3D bioprinting [186]. Magnetically labeled cells were
magnetically printed into rings in 96 well plates, which then contracted or dilated over
time under a battery of vasodilators. This technology represents a rapid and robust in
vitro assay that mimics native 3D tissue and allows for high throughput analysis.
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6.4 Using Janus Magnetic Cellular Spheroids for High Throughput Drug Screening
While building tissues and organs represents an exciting application of cellular
spheroids, the technology is also applicable to other areas of science. Pharmaceutical
companies have been actively partnering with bioprinting groups to fabricate microtissues that can be used for high throughput screening of drugs. For example, Roche has
partnered with Organovo to develop model kidney and liver model tissues for the
screening process [66]. Organovo recently launched the exVive3D liver tissue test kit and
intends to use it to provide better predictors of liver toxicity earlier in the research
pipeline. Souza and coworkers have partnered with the Houston Methodist Research
Institute and reported the use of a magnetic levitation high throughput system to
biofabricate tumor models for cancer research [67]. Clearly, pharmaceutical companies
are interested in the high throughput potential of spheroids and mini-tissues because it
can more accurately mimic the native environment when compared to 2D models. Of
course, the technology can save pharmaceutical companies a lot of money for in vitro
testing and can even potentially reduce animal and human trials if human cells are used.
Our lab has fabricated cellular spheroids with and without magnetic nanoparticles
that maintain viability through 7 weeks [78]. We also possess the capability to culture
hundreds of spheroids at a time using 96 well plates. Future work should include testing
individual spheroids and rings composed of spheroids with a variety of vasodilators
(blebbistatin,

forskolin,

and

verapamil)

and

vasoconstrictors

(norepinephrine,

phenylephrine and U46619) and compare to values for native tissues. Here, individual
cell types or co-culture tissues can be fabricated and tested using the high throughput
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system. This type of testing can give an indication of functionality of the formed
spheroids over time to see if it can compare to native tissues.
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